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INTRODUCTION 
Any abrupt change in diet may induce unexpected consequences. 
Never yet in nutrition have we been able to isolate one nutrient from 
all the others in its metabolic effects. Neither a significant in­
crease nor decrease in intake of a' single nutrient will have uncompli­
cated, totally predictable effects. An increased intake of one nutrient 
will influence the requirement for other selected nutrients. The host of 
interrelationships among nutrients complicates attempts to ameliorate a 
single physical need by a unique dietary alteration. Such is the case 
with fat-altered diets. 
Since 1952 there have been repeated reports that dietary polyun­
saturated fat (PUFA) is associated with lowered serum cholesterol 
(Kinsell et al. 1952, Ahrens et 1954, Hegsted et 1965, Grundy 
and Ahrens 1970). These reports held great promise for a dietary means 
of protection from cardiovascular heart disease, one of the major medical 
concerns of developed nations. Prompted by these results, the American 
Heart Association and the U.S. Senate Select Committee on Nutrition and 
Human Needs have recommended that we increase intake of PUFA. Recent 
dietary guidelines issued by the USDA and DHEW suggest reduction of 
saturated fat but not an increase in PUFA (U.S.D.A. and D.H.E.W. 1980). 
Many have been convinced to alter their diets radically. Consumption of 
PUFA in the U.S. has risen steadily (Rizek et al. 1974). This dietary 
change has occurred, however, without regard to the other effects 
such a diet may produce. The benefits of a high PUFA diet are 
not entirely clear, for there are conflicting results. Not all re­
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searchers have been able to reduce serum cholesterol by raising dietary 
PUFA (Nichols et 1976) . Jackson et al. (1978) have provided a comprehensive 
review of the contradictory evidence and some reasons for the diverse 
results. 
Fear of cardiovascular heart disease is not the only impetus for 
changes towards diets relatively rich in PUFA. Patients maintained on 
long-term total parenteral nutrition (XPN) must receive essential fatty 
acids (EFA) in order to avoid manifestations of deficiency, and the lipid 
emulsions commonly used in such circumstances have P/S ratios of 7.3 and 
over (Silberman et 1977). Recent observations on cystic fibrosis 
patients suggest that at least part of the disease is due to an error in 
EFA metabolism (Campbell et al,. 1976, Chase 1976). Rosenlund et al. 
(1977) and Elliott (1976) have fed increased levels of maize oil and 
soybean oil, respectively, with noticeable improvement in cystic 
fibrosis patients. 
Unfortunately, there is mounting evidence of danger in high PUFA 
diets. Linoleic acid appears to accelerate tumor growth (Rao and 
Abraham 1976, Hopkins and West 1977b). Pinckney (1973) observed pre­
mature skin aging and a ruptured spleen from excessive Ingestion of 
PUFA. Heng (1977) showed alteration in the structure of cardiac muscle 
and in its distensibility related to unsaturation of dietary fat, while 
others have observed increased incidence of respiratory distress in 
laboratory animals on high PUFA diets (Richards 1979). Rats aged 6 to 
9 months fed mixed fats performed significantly better in a discrimina­
tion learning situation than rats fed 20% safflower oil. Moreover, the 
latter rats appeared to have a reduced lifespan (Harman et 1976). 
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Higgins (1979) reported decreased growth in young rats fed 38% of 
calories as safflower oil. Furthermore, it is believed that increasing 
the PUFA intake increases the dietary requirement for vitamin E (Horwitt 
1962, Jager 1972, Harris and Embree 1963). 
Dietary lipid is known to alter tissue lipid composition. High 
PUFA intake enriches tissues with PUFA (Danon et al. 1975, Carroll 1965). 
The consequences whether beneficial or dangerous are not yet fully 
known. Membrane structure and functional characteristics will cer­
tainly be affected, for polyunsaturated fatty acids (PUFAs) are vital 
components of mammalian membranes (Metzler 1977). 
A major use of PUFA in the body is to serve as substrate for 
prostaglandin (PG) synthesis. The PGs have been observed in nearly 
all tissues and appear to be potent local regulators of varied func­
tions: vasoconstriction, vasodilation, smooth muscle contraction and 
relaxation, bronchial dilation and constriction, platelet aggregation, 
lipolysis, reactions mediated by level of cyclic AMP, neural transmission, 
inflammation, intraocular pressure (Karim and Hillier 1972) . There are a host 
of different PGs, all related in structure, being derived from the 20-carbon 
prostanoic acid skeleton but differing in double bond placement, side-
chain substituents, and placement of hydroxyl and keto groups. These 
varying PGs frequently have opposing functions (Mathe et al. 1977). It is 
probably the balance among varying PG forms that allows fine, immediate 
control of localized events. Researchers have recently established that 
dietary intake of PUFA is associated with altered synthesis of PGs 
(Mathias and Dupont 1979). Whether the change in prostaglandin syn­
thetic potential is the mechanism whereby dietary PUFA exerts its 
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influence is not fully established but currently is an accepted, 
working hypothesis. 
The purpose of this work is to explore the Interrelationships of 
high PUFA diets and dietary a-tocopherol, the most common form of 
vitamin E. We propose to test the hypothesis that (1) increased in­
takes of PUFA may produce a secondary vitamin E deficiency and, as a 
corollary, (2) that increasing intakes of crtocopherol may ameliorate 
certain of the ill effects of high PUFA diets, specifically by altering 
the tissue level of PG precursor fatty acids and by altering tissue PG 
synthetic rate. 
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REVIEW OF LITERATURE 
Fatty Acid Composition 
Livestock producers were probably the first to observe that diet 
might influence the lipid composition of animal tissues. While pigs 
fed starchy cereals had hard adipose, those fed peanut-meal had soft 
adipose tissue (Holman 1964). When controlled nutritional studies 
regarding fat source became a reality with advancing technology, it 
was recognized that dietary fatty acid patterns could be reflected in 
tissue fatty acid patterns. Early studies focused on serum and adipose. 
Hirsch et al. (1960) reported that serum lipids in humans showed an 
increased linoleate content in response to a corn oil diet. They also 
observed an effect in adipose tissue but believed it to be a slow, 
gradual response. Repeated observations by many researchers confirmed 
the effect of dietary lipid on serum and adipose. Indeed, the fatty 
acid composition of serum and adipose was strongly representative of 
dietary lipid in laboratory animals (Leat 1963, Holman 1964, Carroll 
1965) and in humans (Dayton et 1966). 
Veerkamp £t (1962) made extensive analyses of the fatty acids 
of lipid fractions of various tissues from several species. Dietary 
variables were not included in the experiment. The rats were given a 
commercial diet which was 6% fat (51% linoleic acid). The reported 
fatty acid patterns of neutral lipids in depot fat, liver, kidney, and 
lung can serve as useful references when considering the effect of 
varying dietary fat. 
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As research results have accumulated, we have found comparisons of 
corn oil, safflower oil, soybean oil, beef tallow, lard, cod liver oil, 
and butter fat in respect to their influence on serum and adipose fatty 
acid compositions. Metabolic studies in adolescent boys comparing 
safflower oil and beef tallow revealed statistically significant dif­
ferences in C16:l, C18:l, and C18:2io6 in serum lipids. When comparing 
corn oil and butter oil, researchers again found significant differences 
in serum oleate and linoleate. Corn oil and safflower oil, rich sources 
of linoleate, were both capable of elevating serum linoleate (Kies 
et al. 1978). 
Another investigator compared safflower oil and coconut oil com­
bined to produce varying P/S ratios and found that adipose tissue pre­
dicted the lipid composition of diet (Higgins 1979). A five-year study 
in elderly men compared the response of serum and adipose to a conven­
tional diet and a diet in which unsaturated fat was substituted for 
saturated fat. Both diets contained fat at 40% of calories, which ap­
proximates current American and European intakes (Dayton et 1966). 
On the high polyunsaturated fat diet, linoleic acid increased signifi­
cantly in all serum lipid fractions. The level of arachidonic acid 
rose slightly in triglycerides but was unchanged in other fractions, 
while palmitate and stearate decreased in cholesteryl esters, phospho­
lipids, and triglycerides. The linoleic acid content of adipose rose 
from 11% of total fatty acids at the initiation of the experiment to 
32% at the termination five years later. 
So well established was the correlation of dietary and adipose 
fatty acid patterns that Beynan et al. (1980) proposed a direct 
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mathematical relationship between them. In fact, they asserted that 
measurement of the fatty acids of adipose may be used to identify whether 
or not individuals are faithfully adhering to recommended diets. 
Research has also been directed at other tissues and organs to 
elucidate the role of dietary fat in altering their composition. Carroll 
noted in a review paper (1965) that many studies of serum and liver had 
been conducted. Today we may add that there is also information on 
brain, kidney, heart, skeletal muscle, adrenal gland, erythrocytes, 
platelets, and retina. Only a few investigators have explored fatty 
acid composition of lung. Liver, serum, and adipose, due to their 
pivotal position in lipid transport, clearance, synthesis, and storage 
reflected, as expected, the influence of dietary lipid. Brain, 
although the contribution of dietary fat thereto was limited, also 
showed significant changes (Carroll 1965). After feeding cod liver oil 
to rats, Rieckehoff et al. (1949) found that the lipid of the heart was 
similar in fatty acid composition to the oil fed. In rat muscle and 
liver dietary corn oil produced increased levels of linoleate, while 
a beef fat diet produced increased levels of oleate (Gurr et al. 1976). 
In a study of the effect of arachidonate and dihomo-Y-linolenate on the 
fatty acid composition of plasma and tissues, researchers concluded 
that the arachidonate content of tissues could be substantially in­
creased by a high dietary intake of arachidonate. The same phenomenon 
occurred with dihomo-Y-linolenate (Danon et £l. 1975). As the experi­
ment was designed, the animals ate a commercial laboratory chow ad 
libitum and were given 300 mg ethyl arachidonate daily (or ethyl 
dihomo-Y-linolenate) by stomach tube. Arachidonate is generally present 
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in the diet in small amounts. Thus, the rats' ingestion of 300 mg 
daily, which is approximately 5% of calories, while appearing on one 
hand to be a high arachidonate intake, is on the other hand quite 
modest by comparison to linoleate intakes at 10-16% of calories on 
vegetable oil diets. Enrichment of all major lipid classes occurred — 
triglycerides, cholesteryl esters, phospholipids, and free fatty acids. 
Further studies of the metabolism of dihomo-Y-linolenate showed that oral 
administration of this fatty acid resulted in its incorporation in tissue 
lipids (Hassam and Crawford 1978b). 
The fatty acid pattern of the triglyceride fraction represents 
dietary fat to the greatest extent, while the phospholipid fraction is 
least variable (Higgins 1979). Cholesteryl ester fatty acid response 
to diet varied with the tissue; hepatic CE was more sensitive to dietary 
fatty acid composition than was plasma CE. Pulmonary nonphospholipid 
fraction was more responsive to dietary fat alterations than were cardiac 
and renal nonphospholipid fractions. Pulmonary phospholipid P/S ratio 
varied from 0.41 to 0.45 when dietary P/S ratio was varied from 0.1 to 
8.6. Thus, the phospholipid fraction of lung hardly altered despite 
major dietary fat alterations (Higgins 1979). Fine et al. (1980) con­
firmed the fact that platelet phospholipid fatty acid composition was 
unaffected by P/S ratios from 0.4 to 5.5. Those tissues containing 
much triglyceride will exhibit the greatest compositional response 
to dietary fat profile. 
Research directed at refining our perceptions has produced evidence 
that dietary fatty acids have not only macro but also micro effects 
on tissue lipid composition. Using mice, Tsang et al. (1980) found 
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lymphocyte lipids reflected the FA composition of the diet after only 
two weeks. Not only organs and cells but also subcellular organelles 
may show lipid changes. Witting et al. (1961) showed the fatty acid 
composition of rat hepatic mitochondrial lipids was readily altered by 
dietary fatty acid variations. Depending on diet, fatty acids could 
readily displace one another and accumulate in brain mitochondria, erythro­
cytes, and heart tissue (Century et al. 1963). Hepatocyte plasma 
membranes contained elevated linoleate and arachidonate when the diet 
was high in PUFA (Hopkins and West 1977a). 
Pulmonary fatty acid composition 
Pulmonary fatty acids have had less attention than those of other 
organs and tissues. It is unfortunate that investigators of lipid 
metabolism have so often overlooked the lung while focusing on other 
organs. Although it is true that the total lipid content of lung tis­
sue is low, nevertheless pulmonary lipid metabolism is highly active. 
The lung engages in vital lipogenesis for the surfactant; free fatty 
acids are rapidly esterified; fatty acid oxidation is swift in lung. 
The lung has been called "a titan of lipid metabolism" (Tierney 1974), 
In fact, due to a limited use of carbohydrate by adult lung, lipids may 
be the major source of acetyl-CoA in pulmonary mitochondria. 
Much research on lung lipids has dealt with elucidation of the 
composition and chemistry of pulmonary surfactant. The pressure on 
alveoli is so great that the air sacs would collapse were it not for the 
presence of surface-active materials that reduce alveolar interfacial 
tension. Frosolono et al. (1970) reported successful isolation and 
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characterization of the surfactant fraction of lung. Identified as 
dipalmitoyl-phosphatidylcholine (DPPC), it was shown to consist of 
68% palmitate, 7% palmitoleate, 7% stearate, 8% linoleate, and 8% 
an unidentified fatty acid. 
Observations of the unusually high pulmonary content of saturated 
16- and 18-carbon fatty acids compared to other mammalian constituents 
led to further purifications and analyses of the surface-active material. 
King (1974) reported the composition to be 50% fully saturated phosphatidyl 
choline (primarily palmitate), 25% monoenoic phosphatidylcholine, and 
small amounts of other phospholipids, proteins, phosphatides, and 
cholesterol. The saturated phosphatidylcholine lowers alveolar inter-
facial tension, while the monoenoic phosphatidylcholine and cholesterol 
provide increased molecular mobility and adsorption to the alveolar 
interface (King 1974). Repeated analyses of fatty acid composition of 
pulmonary surfactant showed very high palmitic acid content (Sanders 
and Longmore 1975). Therefore, when total lung lipids were analyzed, 
a striking feature was the contribution of surfactant and the consequent 
high proportion of saturated fatty acids (Kehrer and Autor 1978, 
Donovan al, 1977) . 
Essential Fatty Acids 
Of particular interest in the study of dietary fat alterations and 
their effects on the body has been the role of essential fatty acids 
(EFAs) and the occurrence of essential fatty acid deficiency. Burr and 
Burr (1929) first recognized the essentiality of certain fats in the 
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diet of laboratory rats. The deficiency symptoms they observed were 
scaly skin lesions, necrosis of the tail, impaired growth, and renal 
degeneration. Further studies identified linoleic acid (C18:2ti6) as 
the critical dietary component. Over the years there has been in­
decision among nutritionists as to the precise fatty acids to be 
considered dietary essentials. Of linoleic acid, there is no doubt. 
In 1974 the National Research Council identified arachidonic acid as es­
sential. In 1980 the National Research Council identified linoleate 
as the primary dietary EFA and arachidonate as a minor contributor. Very 
little arachidonate occurs in the average diet (Brignoli et al. 1976, 
Weihrauch et al. 1977); and humans, rats, and other species are capable 
of synthesizing arachidonate from linoleate. Until recently, it was 
believed that the domestic cat lacked the A-6 desaturase enzyme neces­
sary for arachidonate synthesis (Rivers and Hassam 1975). However, 
Stephan and Hayes (1978) presented evidence that even the cat can thrive 
on a diet whose only fat source is linoleate. 
The desaturase enzyme system appears to be very active under "normal" 
conditions, although many factors influencing its activity have been 
identified — (1) insulin, (2) dietary protein, (3) dietary carbohydrate, 
(4) quantity of endoplasmic reticulum, (5) relative amounts of competi­
tive fatty acid substrates (Brenner 1974), and (6) dietary iron (Rao 
et al. 1980). No doubt, many more factors also influence the desaturase 
system. Dietary arachidonate has been shown to express an essential 
fatty acid potency that is two to three times that of linoleate, as 
measured by its ability to reverse EFA deficiency symptoms (Crawford 
et al. 1978). 
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Much discussion has occurred concerning the dietary necessity of 
linolenate or the iu3 fatty acid family. Takehisa and Kimura (1977) 
reported dermal symptoms in rats were not prevented by dietary linolenic 
acid. The rats showed epidermal thickening and abnormally increased 
phospholipid activity in the skin, classic signs of EFA deficiency. 
Leat and Northrop (1979) also failed to show adequate protection by 
linolenate. Although dietary linolenate was capable of supporting 
growth and gestation, its addition to the diet resulted in severely 
impaired parturition. The explanation was that linolenate was in­
capable of serving as substrate for PG synthesis, and PCs were neces­
sary for successful parturition. These studies, however, do not prove 
that linolenate is nonessential, only that it is inadequate in isola­
tion from other dietary fatty acids. Crawford e^ al. are major ex­
ponents of the belief that a-linolenic acid or other u)3-fatty acids 
cannot be dismissed as nonessential (1978). They supported their con­
tention with comparisons of the triene:tetraene (T/T) ratios in blood 
phospholipids of infants. Infants fed cow's milk (very low in 
linolenate) had T/T = 0.2-0.3. On the other hand, infants fed human 
milk (relatively high in linolenate) had T/T = 0.05. Crawford and as­
sociates believed these results, coupled with the presence of tu3-fatty 
acids in brain and retinyl lipids were compelling reasons not to neg­
lect linolenate. Tinoco et (1978), having observed orlinolenic 
acid in rat and human retinal lipids, rat synaptosomal membranes, and 
human cerebral gray matter, agreed; however, attempts to provoke 
a-linolenate deficiency apparently failed. The authors reported that 
withholding dietary a-linolenate had no effect on growth, reproduction, 
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behavior, or general fatty acid composition in any lipid class in any 
tissue. 
A further problem in assessment of EFA requirement has been quantita­
tive. If we assume linoleate as the major EFA, how much is needed? 
The generally accepted level, based on ability to prevent plasma and 
hepatic T/T ratio from rising above 0.4, has been 1-2% of calories as 
linoleate (Alfin-Slater and Aftergood 1968, Holman 1970). In a study 
with young female rats, Hassam and Crawford (1978a) observed their food 
efficiency did not improve until linoleic acid intake reached 4% of 
dietary energy. From a study of human adult males on total parenteral 
nutrition (TPN), Richardson and Sgoutas (1975) also concluded the re­
quirement should be set at 4% of calories from linoleate. The 1980 
edition of Recommended Dietary Allowances suggests 8-10% of calories as 
linoleate may be beneficial to at least a portion of the United States 
population (National Research Council 1980). 
For the purposes of our study, we considered EFA deficiency to be 
a complete dietary absence of a-linolenate, linoleate, and arachidonate. 
Experimental EFAD diets 
For laboratory observations two basic dietary regimens have been 
employed to induce EFA deficiency; (1) the fat-free diet, and (2) the 
saturated fat diet. In the fat-free method researchers rigorously 
excluded any fat from the diet, providing usually 20% of calories as 
protein and the remaining energy from sucrose. Due to generous body 
stores of EFA, this diet required lengthy feeding to produce either 
clinical or biochemical symptoms of EFA deficiency — in mice 8 weeks 
(DeWille et al. 1979), in rats 15 weeks (Bohles e_t 1976) to 28 
weeks (Kaa 1976). Other investigators felt the only way to deplete 
body EFA pools was to feed a fat-free diet to the mother and so prevent 
the offspring from accumulating EFA from birth (Jonsson et al. 1979). 
The second experimental deficiency diet contained varying amounts 
of fat (27o to 30% of dietary energy as fat) but rigorously excluded 
polyunsaturated fatty acids. Thus, the dietary fat was necessarily rich 
in saturated fatty acids or medium and short chain fatty acids. Hydro-
genated coconut oil (Williams £t 1972), medium chain triglycerides 
(Hirono et £l. 1977), and hydrogenated fish oil (Kaa 1976) all were 
used. Comparisons of the experimental diets repeatedly showed that the 
presence of saturated fat in the diet accelerated and exacerbated the 
deficient state (Deuel e^ al. 1955, Alfin-Slater et al. 1965, Williams 
et al. 1972). Williams et £l. (1972) compared 25% hydrogenated coconut 
oil with a fat-free diet. The saturated fat diet resulted in more severe 
growth depression and dermal lesions than were observed on the fat-free 
diet, although the fatty acid patterns in tissues were not markedly 
different. Both diets produced the characteristic EFA deficient fatty 
acid profiles. The authors concluded that the hydrogenated coconut oil 
either interfered with EFA utilization or had an unknown metabolic ef­
fect. Although both fat-free and saturated fat diets produced EFA 
deficiency, they were not identical in effect. There was evidence 
that hepatic enzymes adapted to a fat-free diet by increasing lipogenic 
activity (Romsos and Leveille 1974). The presence of fat in the diet, 
any fat, reduced this enzymatic activity to control levels (Tepperman 
and Tepperman 1970). Similarly, presence of fat in the diet may have 
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prevented a decrease in activity of lipolytic enzymes, and thus, the more 
rapid appearance of EFA deficiency resulted from continued oxidation 
of EFAs rather than conservation. The fat-free diet may be criticized 
on two accounts. A fat-free diet brings about sharp alterations in 
lipid-metabolizing enzymatic activity. A fat-free diet is of lower 
caloric density than a diet containing a moderate level of fat. Low 
caloric density might make it difficult for an animal to eat adequate 
quantities of food to maintain body weight. 
Investigations dealing with hydrogenated coconut oil (HCO) diets 
have also considered the effects of varying levels of casein. Rats were 
fed either 25% HCO and 20% casein or 25% HCO and 25% casein. After 
four weeks the group on the higher casein diet had maintained body weight 
better than the other group, although after eight weeks, weight dif­
ference between the two groups had disappeared. Thus, the higher casein 
diet appeared to provide moderate protection against the growth depres­
sion usually seen on EFA deficient diets (Williams et a^. 1972). Hill 
and Holman (1980) varied the casein in EFA deficient diets from 5 to 
40%. Dermal signs increased in severity at levels of protein over 30%, 
while the T/T ratio of liver phospholipid was most elevated at low pro­
tein levels. Body weight increased sharply when protein content of the 
diet was raised from 5 to 20%, but there was little improvement in 
body weight at higher protein intakes. Thus, dietary protein is an 
important variable in expression of EFA deficiency. 
16 
Fatty acid Interactions 
The nutritional and metabolic interrelationships among fatty acids 
prevent simple considerations of isolated fatty acids, Holman (1964), 
Mohrhauer et al. (1967) and Mead (1961) were among the leaders in 
elucidating polyenoic fatty acid interactions. Elghteen-carbon fatty 
acids occur naturally in three families — u)3, oj6, and u)9 — according 
to position of the C-C double bond nearest to the methyl terminus. All 
three families undergo desaturation and elongation, competing for the 
same enzymatic system. Dependent upon the initial fatty acid, the end 
products will differ. Figure 1 shows the three fatty acid families 
and their metabolism scheme. As will be noted, the A6 desaturase can 
act upon oleate, linoleate, and a-linolenate; and this desaturation may 
occur prior to elongation. Since all three substrates compete, the 
production of C20;3iu9 can be suppressed by the presence of C18:2u)6. 
Thus, in EFA deficiency, when C18;2(u6 is lacking, appearance of C20:3w9 
is to be expected. Holman (1964) clearly showed that depression of the 
metabolites of one family is occasioned by feeding members of another 
family. Brenner (1974) reported that C20:4uj6 inhibited the conversion 
of C18:lu# to C20:3uj9. Saturated fatty acids had no inhibitory effect. 
Alpha-linolenate was a stronger competitor than oleate, having a smaller 
Kn. Therefore, presence of any m3 or m6 fatty acid suppressed synthesis 
of C20:3(ju9. The rate-limiting enzyme of the entire desaturation-
elongation system was believed to be the A6-desaturase (Hassam and 
Crawford 1978b). Perhaps cystic flbrotics, who appear EFA deficient, 
although no C20:3u# is apparent, lack /^-desaturase (Rivers and Hassam 
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Figure 1. Desaturation and elongation of C18 fatty acids (after Mead 
1961) 
1975). A recent observation suggested that a fat-free, iron-sufficient 
diet stimulated A6-desaturase activity (Rao ^  3%. 1980). 
Importance of EFA deficiency 
Although EFA deficiency was first reported over fifty years ago, 
there was but minor interest among researchers who believed it to be of 
little practical concern in humans. The deficiency was not recognized 
in general populations, humans had generous reserves of EFA, and the 
food supply provided more than adequate EFA. In the last decade, how­
ever, interest has burgeoned. Essential fatty acid deficiency is no 
longer an impossibility. The appearance of long-term TPN for surgical 
and other traumatized patients, of intravenous feeding of premature 
or other at-risk infants, and recognition of fat malabsorption syndromes 
have all mandated a fuller understanding of EFA deficiency. Richardson 
and Sgoutas (1975) reported EFA deficiency appeared in adults within 
only three weeks on TPN, and other researchers confirmed the reality of 
EFA deficiency today (Fleming et sX, 1976, Wene et aJL. 1975). Biochemical 
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evidence of EFA deficiency could be detected in infants within two 
weeks, although dermal symptoms were slower to appear (O'Neill et al. 
1977). 
Consequences of EFA deficiency 
The standard identification of EFA deficiency has been by the 
trienertetraene (T/T) ratio proposed by Holman (1960). In normal 
serum and tissues one detects only traces of eicosatrienoic acid (C20: 
31^). Thus, the ratio of C20:3u)9 to C20:4(u6 is very small. In EFA 
deficiency, on the other hand, eicosatrienoic acid increases with 
progress of the deficiency, while the level of eicosatetraenoic acid 
(C20:4w6) is believed to decrease. Thus, the T/T ratio rises. A T/T 
ratio greater than 0.4 is considered to signal EFA deficiency. The 
T/T ratio has been variously determined in plasma, liver, heart, and 
other tissues and from total lipids, phospholipids (PL), and other 
lipid classes. Depending on the method of determination and depth of 
deficiency, ratios were reported from 0.2 in blood PL (Crawford et al. 
1978) to 1.6 in skin (Skolnik et aj.. 1977) to 2.9 in salivary gland 
(Alam and Alam 1978) to 3.4 in liver (Hassam and Crawford 1978a). 
Bohles et al. (1976) believed the T/T ratio of the cholesteryl ester 
(CE) or PL fraction of plasma was the most sensitive indicator of EFA 
intake. Triglyceride had a slow turnover rate. Total lipid, containing 
a large amount of triglyceride was, therefore, less responsive to 
dietary alterations. 
With a resurgence of interest in EFA deficiency came reports of 
subtle consequences of the dietary lack. To the earlier and more 
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obvious clinical symptoms, researchers added a host of observations at­
tributable to the EFA deficiency disease. DeWille et al. (1979) 
depleted mice of EFA for 70 days. At the end of 30 days, there was no 
difference in body weight, thymus, or spleen weights in EFA deficient or 
control animals. However, by 70 days the deficient mice had significantly 
reduced body weights, although their energy intake did not differ from 
control animals. Fatty livers have frequently been reported in EFA 
deficiency. Decreased hepatic secretion of triglycerides was suspected. 
Huang and Williams (1979) tested the postulate and found just the op­
posite. Their animals not only had fatty livers but also a twofold 
increase in hepatic triglyceride release. The authors speculated, 
therefore, that the hepatic lipidosis must be due to enhanced hepatic 
lipogenesis in the deficient state. Mitochondria were distorted and 
enlarged by lipid deposits in liver (Richardson and Sgoutas 1975) and in 
lung (Edmonds et al. 1975). Stephan and Hayes (1978) reported depressed 
appetite, mild anemia, and lowered plasma a-tocopherol in EFA deficient cats. 
Mature male rats fed 10% of dietary energy as HCO were protected 
against oxygen toxicity as compared to rats fed either standard laboratory 
chow or a 10% cod liver oil diet (Kehrer and Autor 1978). Thus, not all 
the consequences of EFA deficiency are dire. 
Dermal symptoms are late-appearing. O'Neill et £l. (1977) recog­
nized EFA deficiency in human infants biochemically long before 
observing hair loss, hair depigmentation, and poor wound healing. Jonsson 
et al. (1979) verified and quantified the slow rate of wound healing. 
Skolnik et (1977) reversed the deficiency effects on skin by topical 
application of safflower oil. Within 21 days not only had the T/T of 
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skin returned to normal, but also the T/T of serum had dropped prominently. 
Cutaneous treatment with safflower oil improved erythrocyte and plasma 
fatty acid patterns as well as skin symptoms, suggesting that in EFA 
deficiency the skin was highly permeable and oil readily absorbed 
(Bohles et al. 1976). Takehisa and Kimura (1977) reported an increased 
phospholipid synthetic activity in EFA deficient skin. 
As has previously been implied, the fatty acid pattern of tissues 
was greatly altered when EFA was lacking in the diet. The typical 
change in FA pattern caused by EFA deficiency, no matter the tissue or 
the lipid fraction, involved a rise in C20;3u)9, C16:l, and C18:l and a 
concomitant decline in C18:2(ju6 and C20:4u6 (Bohles ^  al. 1976, Holman 
1964, Kehrer and Autor 1978). Drastic FA composition changes were re­
ported in salivary gland (Alam and Alam 1978), endocrine system (Panos 
and Finerty 1954), oral palatal epithelium (Lekholm 1976), serum and 
adipose (Privett e^ al. 1965), liver (Peluffo et al. 1976, Fallani et al. 
1976), lung (Kyriakides et al. 1976), brain (Sun 1972, Odutuga 1977), 
and erythrocytes (Hirono e^ 1977). Other lipids were also affected 
by the deficiency. Brain cell and membrane structures were shown to be 
disturbed while cerebroside and sphingomyelin content of brain was di­
minished (Odutuga 1977). 
As might be expected, EFA deficiency has profound effects on 
enzymatic activities. Hazinski et (1975) found elevated pentose 
cycle activity in isolated adipocytes which was not reversible by the 
addition of the EFA metabolite prostaglandin E^. Brivio-Haugland et al. 
(1976) speculated that membrane structure was altered so as to reduce 
binding affinity, change the number of receptor sites, or alter concentra-
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tion of cofactors for enzyme activation. 
Essential fatty acid deficient animals had a reduced inflammatory 
response (Denko 1976) and a reduced humoral immunity response (DeWille 
et 1979). Essential fatty acid deficient human infants had im­
paired platelet aggregation in response to ADP compared to other low 
birth-weight infants. Clinical hemorrhage occurred in 80% of EFA 
deficient infants (Friedman et al. 1977). Essential fatty acid deficiency 
was implicated in the occurrence of hypertension. Genetically hyper­
tensive rats had a lower level of C20;4(u6 in platelets than normal 
rats, which suggests an increased requirement for EFA in hypertensives 
(Lehmann £t 1977b) . 
The effects of EFA deficiency on lung are manifold. Not only did 
EFA depletion enhance survival from 0^ toxicity as previously reported, 
but also rat lung lipids reflected the typical EFA deficiency pattern 
(Kehrer and Autor 1978). Table 1 has a comparison of pulmonary fatty 
acid composition in EFA deficiency and sufficiency. Weanling male rats 
fed a fat-free diet for 24 weeks had reduced secretion of pulmonary sur­
factant and enlarged mitochondria with cristae packing the intramito-
chondrial space (Edmonds et aJL. 1975). Friedman and Rosenberg (1979) 
isolated human pulmonary surfactant for FA analysis and reported de­
creased palmitate and palmitoleate and increased oleate under condi­
tions of EFA deficiency. It was a striking observation that although 
plasma palmitate rose during EFA deficiency, pulmonary surfactant 
palmitate dropped. This alteration in the FA composition of surfactant 
may impair its surface active qualities. Indeed, Hopkins et (1963) 
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Table 1. Fatty acid composition of mature rat lung lipids after 33 days 
on experimental diets (from Kehrer and Autor 1978). 
Triglyceride Phospholipid 
% of total FA % of total FA 
Fatty acid HCO* CLOb HCO CLO 
16:0 24.7 21.9 30.0 33.9 
16:1 8.0 7.7 8.6 8.1 
18:0 5.2 4.9 13.5 11.7 
18:1 36.9 36.8 18.3 15.3 
18:2 1.6 3.4 1.1 0.8 
18:3 0 9.5 0 2.3 
20:4 0.3 2.7 17.3 7.1 
^HCO = hydrogenated coconut oil, 10% of calories. 
^CLO = cod liver oil, 10% of calories. 
reported that EFA deficiency caused a respiratory disease syndrome in 
chickens. Kyriakides et al. (1976) independently showed the palmitate con­
tent of pulmonary tissue to be decreased in EFA deficiency and the 
surfactant activity of lung lavage phosphatidylcholines to be impaired, 
Refeeding of 4% safflower oil reversed the effects. Gross lung morphology 
was not altered in EFA deficiency, although Type II alveolar cells were 
affected (Friedman and Rosenberg 1979). 
As EFAs are precursors for prostaglandin (PG) formation, one would 
expect EFA deficiency to be apparent in PG metabolism. Indeed, explana­
tions for the previously mentioned hypertension, impaired platelet ag­
gregation, inflammatory and immune responses may rest in the PG 
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synthetic capacity of the appropriate organs and tissues. Friedman 
et al. (1978) reported a decrease in a PGE metabolite in urine in human 
infants with EFA deficiency. Prostaglandin content of brain was 
diminished and platelet PG formation reduced in EFA deficiency (Hassam 
et al. 1979). Alterations of kidney PG metabolism occurred (Van Dorp 
1971). Ziboh et aX. (1974) reported a decline in PG synthetic capability 
in EFA deficient animals. Attempting to identify the cause, they found 
that an unsaturated FA occurring in the lipids of EFA deficient rats 
directly inhibited the cyclooxygenase activity of sheep vesicular glands. 
This inhibiting fatty acid was probably C20:3(u9, and it appeared to act 
by competitive inhibition. The effect, however, was insufficient to 
explain fully the decrease of synthetic capacity in EFA deficient animal 
tissues. 
Bailey (1977) showed that several types of cells were able to grow 
and metabolize normally in the absence of EFA, e.g., human skin 
epithelium, human fetal cells, and rat liver parenchyma cells. He 
concluded that EFAs were not required for membrane structural purposes 
and that perhaps their sole essential biological function was to serve 
as precursors for PGs. However, cell growth and reproduction in culture 
does not signify ability to function properly in the whole organism. 
Ziboh and Haia (1972) found that treating EFA deficient rats with topical 
applications of PGEg cleared the dermal symptoms. Parnham et (1979) 
reported that not all the consequences of EFA deficiency could be re­
lieved by PG supplementation. Hazinski ejt al. (1975) concluded that the 
metabolic effects of EFA deficiency were more complex than simply re­
duced levels of PGs, since in vitro addition of PGE^ had no effect on 
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EFA deficient cells. The role of EFAs as precursors of the PGs is vital 
but is probably not the sole biological function of the EFAs. 
Prostaglandins 
Less than ten years after recognition of the EFAs came the dis­
covery of a vaso-depressor, smooth-muscle-stimulating substance in human 
semen that von Euler (1935) called "prostaglandin." It was more than 
25 years later before the structure of this new substance was determined, 
and that proved to be one of the most fruitful and provocative dis­
coveries of nutritional biochemical science. For the prostaglandins 
were shown to be active metabolites of the EFAs. Prostaglandins have a 
wide distribution in mammalian tissues and in other animal species 
(Normura and Ogata 1976). Prostaglandins and their precursors and 
products participate in a host of physiological processes, usually 
mediating metabolic actions within the cells in which they are 
synthesized. 
Prostaglandin synthesis 
The details of PG biosynthesis are not yet fully described, although 
much progress has been made. The basic requirements for PG synthesis 
include; (1) the prostaglandin synthetase enzyme system — ECl.14.99.1; 
(2) twenty-carbon u)3 or u)6 fatty acids with multiple sites of unsatura-
tion, (3) molecular 0^, and (4) cofactors (reducing agents). Prosta­
glandins of the one series are metabolic products of dihomo-Y-linolenic 
acid. Prostaglandins of the two series are metabolic products of 
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arachidonlc acid. Figure 2 shows the relationships of the u)6 EFAs and 
their PG products. 
C18:2cu6 C18:3u)6 — C20:3m6 — 
PGE^ 
C20;4au6 PGFgQ, 
PGEg 
, 
PGl' 
Figure 2. Generalized scheme of uu6 fatty acid conversion to prosta­
glandins 
Fatty acid substrates for PG synthesis must be nones ter if ied. Because 
the PL fraction is rich in EFA, much attention has focused on phospho-
lipase, and this enzyme has been considered rate-limiting (Russell et al. 
1975), at least for the two series of PGs. Vane (1971) showed that non­
steroidal anti-inflammatory agents, e.g., aspirin and indomethacin, 
inhibit PG synthesis. Lands et (1973) showed that many antioxidants 
also inhibit PG synthesis. 
PGs are rapidly metabolized, having a biological half-life in the 
circulation of a few minutes at most (Vane 1969). Açcording to one 
estimate, more than 80% of the PGE^ was metabolized on a single pass 
through the lung (Ferreira and Vane 1967). Golub et £l. (1975) 
determined that 68% of the PGE^^ was removed from the circulation in one 
transit through the lung, while only 8% of the PGA^ was removed. 
Prostacyclin 
Moncada and Vane (1977) reported the discovery of an endoperoxide 
intermediate in PG metabolism which was 20 to 30 times as potent as 
PGE^ in inhibition of platelet aggregation. This substance, termed 
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prostacyclin or PGI^, was formed exclusively in the vessel wall and 
was, in fact, the major route of endoperoxide metabolism in vessel 
walls. Observations showed the vessel microsomes did not use arachidonate 
to generate PGI^. A new homeostatic mechanism was proposed. "Plate­
lets attempting to stick to the vessel wall release endoperoxides which 
are then used by the endothelial cells to make PGI^ which then repels 
the platelets and stops them from sticking" (Moncada and Vane 1977, p. 
163). Under normal circumstances, the intact vessel wall protects it­
self from platelet deposition. However, vascular damage may impair 
production of the protective prostacyclin and lead to thrombosis. 
Gryglewski et a%. (1978) measured the effects of prostacyclin but 
not prostacyclin itself by bathing rabbit collagen strips with arterial 
and venous blood. They found PGIg was consistently higher in arterial 
than venous blood and concluded that the lung served an important 
endocrine function by continuously generating and releasing PGIg in 
vivo and thereby protecting against intraarterial thrombosis. 
Dembinska-Kiec et (1979) concluded from their observations that 
prostacyclin was the major arachidonate metabolite formed by normal 
lungs. 
Relationship of PCs and diet 
Prostaglandins have potent and complex effects in physiological 
systems. In many instances different PGs have opposing effects. The 
balance among PG forms is probably a mechanism for fine, immediate 
control of local events. Awareness of the multitude of physiological 
effects of the PGs led to concern over the levels of PGs in various 
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tissues. Control of PG biosynthesis appeared to be a method for regu­
lating body functions. Availability of the precursor fatty acids by 
dietary alterations was of practical importance. 
Pros taglandins and EFA deficiency 
Under conditions of EFA deficiency, when precursor levels are low, 
one expects PG biosynthesis to be diminished, Vincent et al, (1974) 
reported that the inhibition of collagen-induced platelet aggregation 
by PGE^ was considerably reduced in EFA deficient rats. However, there 
was no measurement of PGs, Others, reporting on EFA deficiency and PGs, 
implied reduced PG synthesis without actually measuring the PGs (Kupiecki 
and Weeks 1966, Hazinski al. 1975, Ziboh and Hsia 1972). Kaa (1976) 
found that PGEg synthesis in renal medulla of EFA deficient rats actually 
increased. Parnham £t (1979) measured endogenous PG production in 
EFA deficient rats using a bioassay of PGE on isolated rat stomach strip. 
As this method did not adequately differentiate PGs, it is difficult to 
evaluate the results. Nevertheless, the authors showed reduced endog­
enous PG in serum. Other reports also showed that an EFA deficient 
diet reduced PG synthesis (Van Dorp 1971, Weston and Johnston 1978, 
Christ and Nugteren 1970). After examining many batches of animals 
over time, Parnham et (1979) concluded that endogenous PG production 
was an important indicator of EFA status. Depressed PG synthesis in 
EFA deficiency could be due not only to diminished precursor availability 
but also to the competitive, inhibitory presence of C20:3uj9, 
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Prostaglandins and PUFA-rich diets 
Conversely, were increasing levels of dietary EFA accompanied by 
increasing PG synthesis? In an early experiment on this problem. Silver 
et al. (1974) administered large doses of arachidonic acid to rabbits. 
The treatment resulted in sudden death of the animals due to thrombosis. 
Since it had previously been shown that an arachidonic acid metabolite, 
PGFg^, was an aggregatory agent, these results strongly suggested that 
altering the precursor fatty acid level could affect PG synthesis. 
Danon et al. (1975) reported that rat tissues could be enriched with PG 
fatty acid precursors. Ethyl arachidonate and ethyl-dihomo-y-linolenate, 
fed by stomach tube, were incorporated into all lipid classes of the 
tissues observed, but especially into triglycerides. In the same year, 
Hwang et a%. (1975) measured the PGs themselves after different dietary 
treatments. In a paper that is now a classic in the area, they reported 
that serum concentrations of PGE, and PGF„ measured by radioimmuno-
1 2a •' 
assay (RIA) were higher in rats fed 20% corn oil than in those fed 20% 
beef tallow. Although the serum samples were not handled in a properly 
controlled manner at autopsy resulting in some variability, the results 
have been confirmed in many later experiments. By feeding trans-
linoleate to rats for 12 weeks, Hwang and Kinsella (1978, 1979) brought 
about a decrease both in precursor fatty acids and in PG synthesis in 
arterial blood. Feeding linolenate, Hwang and Carroll (1980) confirmed 
that PG synthesis could be regulated by precursor fatty acid supply. 
Prostaglandin and arachidonic acid levels in serum were well correlated 
(Hwang et 1979) . Meydani ejt al. (1978) found that lung PG synthetic 
potential was increased tenfold in rats on a high compared to a low-PUFA 
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diet. Mathias and Dupont (1979) varied the P/S ratio of a 20% fat diet 
between 0.4 and 5.5. No change in PGFg^ and PGEg in lung nor in ten-
minute incubated serum occurred. However, if the P/S ratio of the 
diet were raised to 9, then serum PG levels increased dramatically. 
Dupont et (1978) varied dietary linoleate in graded levels from 0 
through 30% of energy and measured venous serum PGE^, PGEg, and PGF^^. 
Increasing the dietary linoleate content from 5% to 30% produced a 
linear rise in PG synthesis rate for PGE^ (r = 0.86) and PGF2q, (r = 
0.97), but there was no observed alteration in PGE^ synthesis. DeDeckere 
et al. (1979) fed rabbits and rats for four weeks sunflower seed oil, 
hydrogenated coconut oil, or lard. Prostaglandins were measured by 
gas chromatography and bioassay. The authors failed to see an effect 
of dietary fat on PG synthesis. Similarly, Fine ejt (1977) found 
that serum PGE^ was not affected by the P/S ratio of the diet. 
Thus, results are mixed. Not all researchers find a correlation 
between dietary EFA and PG synthesis or endogenous PG. Some of the 
discrepancy is due, no doubt, to differing methods of sample handling 
and differing analytical techniques. 
Prostaglandins are present in tissue in minute amounts. Injury, 
manipulation, sample collection itself stimulate generation of prosta­
noids. During sample storage, PG synthesis continues unless inhibitor 
is added. Even small discrepancies in handling cause major differences 
in PGs measured. Mass spectroscopy is the preferred analytical method 
but has limited sample capacity. Radioimmunoassay can handle large 
numbers of samples but is subject to cross-reactivity and specificity 
problems. The use of standardized, controlled tissue handling and 
30 
similarity in analytical procedures is, therefore, essential for meaning­
ful comparisons. 
Vitamin E 
Vitamin E and polyunsaturated fatty acids are intimately linked in 
the diet and in the body. The consensus holds that vitamin E require­
ment is not a simple, fixed value. While the dietary requirement may 
be influenced by age (Farrell et 1978), environmental influences, 
and toxic materials, the major determinant of vitamin E need is amount 
of PUFA in the diet (Harris and Embree 1963). Generally, the interrela­
tionship of vitamin E and PUFA is expressed as a ratio of vitamin E (mg): 
PUFA (g). Vitamin E is a generic term applying to total tocopherols and 
including a, P, y, 6 forms. Alpha and gamma tocopherols are by far the 
most common in our food supply. Gamma tocopherol is present in vegetable 
oils in higher concentration than a-tocopherol (Bieri and Evarts 1975b), 
but Y"tocopherol has only 20% the biological activity of o;-tocopherol 
(Bieri and Farrell 1976). For the purposes of the present discussion, 
vitamin E is used to indicate vitamin E activity and presumes inclusion 
of total tocopherols unless otherwise specified. 
Vitamin E^ requirement 
In the "Elgin" studies adult males who were maintained on a dietary 
ErPUFA ratio of 0.4 slowly developed vitamin E deficiency as manifested 
by erythrocyte hemolysis (Horwitt 1962). At an E:PUFA ratio equalling 
0.9 patients remained free of undue hemolysis but incurred no reserve, 
for within one week of cessation of supplementation, they exhibited 
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abnormal hemolysis. Thus, the conclusion was that an EtPUFA ratio ap­
proximating 1.6 was more truly adequate. The E:PUFA ratios required 
for adequacy of vitamin E nutriture vary by species. Rats on a 15% 
corn oil diet appeared normal when the E:PUFA ratio was as low as 0.1 
(Harris and Embree 1963). The "average" U.S. diet in 1960 had an 
E;PUFA ratio of 0.616, Because Harris and Embree (1963) were unaware of 
overt deficiency, they concluded 0.6 could serve as a reference ratio 
for adequacy of vitamin E supply. Any diet with an E:PUFA ratio less 
than 0.6 should be considered potentially deficient. 
The use of ratios has been severely criticized as being rigid, 
simplistic, and unrealistic (Witting and Lee 1975a). In diets of 5% 
or 10% fat and graded levels of PUFA with no diet providing more than 
2.75% of calories as PUFA, the levels of PUFA and a-tocopherol in rat 
plasma increased in parallel. This result suggested that increasing 
intake of PUFA was automatically accompanied by increased intake of 
vitamin E. However, when linoleate intake reached 5.5% of calories, 
plasma tocopherol began to drop (Bieri and Poukka 1970). Clearly 
a single ratio was not adequate over a range of PUFA intakes. ,Jager 
(1972) explored this same problem in detail and confirmed the conclusion. 
Using erythrocyte hemolysis in rats as the deficiency symptom, he 
calculated a shift in vitamin E requirement with changing linoleate 
intake. However, the relationship between the intakes of the two 
nutrients was not linear. As linoleate varied from 0 to 50 g/kg diet, 
the vitamin E requirement was fairly stable. As linoleate increased to 
higher intakes, the vitamin E requirement began to rise exponentially. 
Dietary linoleate at up to 7% of calories caused no increase in 
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vitamin K requirement, but when dietary linoleate was over 20% of 
calories, the vitamin E requirement was increased at least 50% (Jager 
1972). 
Dam (1962) showed that increased dietary PUPA increased vitamin E 
requirements. Moreover, excessive intakes of PITFA appeared to precipitate 
vitamin E deficiency symptoms. Erythrocytes from vitamin E deficient 
rabbits were not susceptible to dialuric acid peroxidative hemolysis 
until the rabbit diet was supplemented with arachidonate. Feeding PUFA 
to vitamin E depleted rabbits acutely initiated the onset of hemolysis 
and muscular dystrophy (Brin et al. 1974). Bunnell e^ aj.. (1975) fed 
a low vitamin E diet to men engaged in hard physical labor. One group, 
which received safflower oil, showed a sharp decline in plasma tocopherol 
levels from their normal.1.42 mg/100 ml to 0.5 mg/lOO ml, the minimally 
adequate level. The men had no symptoms of physical or muscular weak­
ness. In an animal study a threefold increase in dietary PUFA depleted 
tissue stores of vitamin E, reducing E:PUFA ratios 26-63% (Bieri £t al. 
1978). 
Vitamin E requirement may be influenced by tissue PUFA levels 
(Horwitt 1962). At low levels of intake (1-2% of calories), linoleate 
and other (u6 fatty acids concentrated largely in the PL. A maximum 
level was reached beyond which the composition of PL no longer altered 
significantly. Thus, at higher dietary levels of linoleate, accumula­
tion occurred in the other lipid compartments. Both phospholipids and 
neutral lipids, therefore, were important in determining vitamin E 
requirement (Witting 1972). The vitamin E requirement was related to 
tissue PUFA. But the tissue PUFA was related to the dietary PUFA. 
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The general trend to increased consumption of PUFA was reflected in 
higher levels of PUFA in the adipose of female college students as 
compared to the early I960's (Witting and Lee 1975b). Adipose linoleate 
levels should be periodically evaluated and vitamin E intakes appropriately 
adjusted (Witting and Lee 1975a). 
Amount of adipose tissue as well as fatty acid composition has 
also been implicated in establishment of vitamin E requirement. Obese 
rats had threefold higher plasma or-tocopherol than normal weight rats 
Bieri and Evarts 1975a). On the other hand, obese rats had less 
Of-tocopherol in lung and heart tissue than the control rats (Bieri and 
Farrell 1976). 
Vitamin E intakes 
While it is well established that dietary and tissue PUFA raise 
the vitamin E requirement and while there has been a continued trend 
in the U.S. to increase PUFA intake, there has been little concern 
over potential vitamin E deficiencies. Recent statistics indicate 
the average consumption of linoleic acid in the U.S. was 23g/person/ 
day (Rizek £t aji. 1974). The average vitamin E intake from the diet 
was no more than 15 mg/person/day (Weiser and Salkeld 1977). In 
Australia a review of diets showed 7 out of 25 were inadequate in 
vitamin E according to established allowances (Mobile and Woodhill 1976). 
Examination of the dormitory food service meals at a Texas university 
revealed the EtPUFA ratio was less than 0.5, potentially deficient 
(Witting and Lee 1975b). Another estimation showed the average U.S. 
diet to have an EzPUFA ratio of 0.43 (Bieri and Evarts 1975b). 
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Failure to be concerned about these presumptively deficient vitamin 
E intakes rests on the comfortable assumption that increasing PUFA in­
take automatically increases tocopherol intake. This assumption has 
been challenged. Very little vitamin E occurs in fats of animal origin. 
The richest source is vegetable oil. Bieri and Evarts (1975b) concluded 
that all vegetable oils were satisfactory sources of vitamin E with 
such EzPUFA ratios as corn oil 0.49, soybean oil 0.60, and safflower 
oil 0.35. However, it was demonstrated that these ratios, as guides 
to adequacy, are useless except at low to moderate fat intakes. Further­
more, absorption of tocopherol may vary. Witting (1975) reported that 
increased ingestion of vitamin E resulted in decreased absorption. Weber 
et al. (1964) found that PUFA actually interfered with crtocopherol 
absorption. Peake et al. (1972) were unable to confirm a differential 
absorption when feeding Qf-tocopherol with either corn oil or lard. More 
recent evidence showed fatty acids were absorbed more effectively than 
tocopherols (Weiser and Salkeld 1977). If this is true, then in­
creasing dietary PUFA may be accompanied by increased dietary E, but 
actual appearance in circulation and body cells of excess PUFA does 
not necessarily mean concomitant appearance of more tocopherol. More­
over, much dietary vitamin E is the less potent y-tocopherol. Even 
if the vitamin E;PUFA ratio of the diet were constant, the a-tocopherol: 
PUFA ratio of the absorbed matter and of the body tissues might be 
variable. 
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Functions of vitamin E 
The functions of vitamin E in the organism are still debated. A 
1976 review of vitamin E (Bieri and Farrell) proposed four roles 
of the vitamin: (1) As an antioxidant. There is extensive evidence 
tocopherols act in this capacity (Dillard et 1978b, Downey et al. 
1978, Hafeman and Hoekstra 1977, Wilson et al. 1978). Vitamin E exerts 
its antioxidant capacity by disrupting the chain generation of free 
radicals in lipid peroxidation. That this is the sole or even major 
role of vitamin E is doubtful for other biological antioxidants exist, 
e.g., glutathione reductase, that appear to be more important in inter­
rupting radical chain reactions. In addition, other antioxidants can­
not prevent all derangements of vitamin E deficiency. (2) As a struc­
tural component of membranes. There is as yet no evidence to support 
this function, although Bonnetti and Novello (1976) reported that 
a-tocopherol was primarily localized within the cell bound to membranes. 
(3) As a regulator in protein synthesis. (4) As a regulator of enzyme 
activity. In vitamin E deficiency several enzymes do alter in activity, 
e.g., muscle creatine kinase, liver xanthine oxidase. 
Effects of deficiency or excess 
Although many fascinating effects of excessive or deficient dietary 
vitamin E have been observed, the succeeding paragraphs will consider 
only the six major effects that suggested the design and hypothesis of 
the present research. These are the effects on (1) hemolysis, (2) 
pulmonary response to oxygen stress, (3) tissue fatty acid patterns, 
(4) tissue tocopherol levels, (5) immunity, and (6) platelet aggregation. 
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The classic vitamin E deficiency test is degree of erythrocyte 
hemolysis in vitro. Although open to criticism as not nutrient-specific 
and insensitive to a range of vitamin E intakes, erythrocyte hemolysis 
is still frequently measured for correlation and comparison with other 
aspects of vitamin E nutriture. Yang and Desai (1977a) reported that 
vitamin E deficient rats exhibited spontaneous red blood cell (RBC) 
hemolysis in saline-phosphate buffer while vitamin E supplemented rats 
did not. Rats received a vitamin E deficient diet with 10% by weight 
molecular distilled corn oil as fat source. Rats receiving no vitamin 
E supplement had 87% hemolysis, while rats receiving 25-25,000 lU/kg 
diet/day dl-otocopheryl acetate had only 2% hemolysis. Although 
graded amounts of dl-a-tocopheryl acetate were fed, there was no dif­
ference in hemolysis once a critical minimum intake was achieved. As 
a measure of vitamin E nutriture, therefore, hemolysis was useful only 
in an either-or situation — either deficient or adequate — telling 
nothing about excessive intakes. A comparison of ot- and y-tocopherols 
confirmed that a-tocopherol protected against hemolysis at lower 
doses than ^-tocopherol (Aftergood and Alfin-Slater 1978). Horn et al. 
(1978) confirmed the relationship of vitamin E and hemolysis in Rhesus 
monkeys. Vitamin E was found to protect against oxidative damage to 
RBC membranes and hemoglobin in rats. Thiobarbituric (TEA) reactants 
were decreased, indicating inhibition of oxidation (Chow 1978). 
Vitamin E appears to have a major protective role in lung. Pre­
mature infants frequently develop respiratory distress syndromes and 
are given respiratory assistance with enriched oxygen atmospheres. 
Prolonged treatment leads to severe toxic effects manifested in lung 
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degeneration and identified as bronchopulmonary dysplasia. Ehrenkranz 
et al. (1978) reported an attempt to forestall development of the 
disease by giving the infants intramuscular injections of vitamin E. 
None of the vitamin E treated infants developed bronchopulmonary dysplasia, 
while half of the control infants did. Vitamin E appeared to modify the 
toxic effects on lung of inspired high 0^ concentrations. This study 
has been sharply criticized (Northway 1978) for poor design, improper 
controls, and biased results. Nevertheless, the theory seems to be 
valid. Oxygen toxicity occurs in the lungs and is associated with in­
creased lipid peroxidation (Dumelin et 1978). Vitamin E is known 
to antagonize lipid peroxidation (Dillard et al. 1978a). Tocopherol 
stores are low in infants, especially in premature infants (Goldbloom 
1963, Wright et 1951). Animal studies support the hypothesis that 
vitamin E protects lung tissue from oxidative damage. When rats on 
diets either low or high in vitamin E for five weeks were exposed to 
ozone, the rats on the low vitamin E diet exhibited greater prolifera­
tion of mitochondria and greater 0^ consumption than the rats on the 
high vitamin E diet. This enhanced response to the ozone challenge 
with a low vitamin E diet suggested that vitamin E increased an 
animal's ability to withstand oxidant stress (Mustafa 1975). Chow 
(1977) confirmed these findings. Similar results have been reported 
in the mouse lung (Menzel ^  1978). Vitamin E supplementation in 
the diet reduced oxidative damage in lung. 
Dietary vitamin E influenced the total fatty acid content of 
plasma (Cho and Sugano 1978). Did tocopherol also influence the fatty 
acid pattern of tissue lipids? In vitamin E deficiency the levels of 
38 
C20:4uj6 rose in liver and gastrocnemius and quadriceps muscles of 
the rat (Bernhard et 1963, Witting and Horwitt 1967, Witting et al. 
1967). Other investigators found that cu6 fatty acids, with the excep­
tion of C20:4ufi rose in phospholipids of vitamin E deficient rats (Lee 
and Barnes 1969). Further attempts to clarify this relationship some­
times failed to demonstrate an effect by vitamin E on FA composition of 
tissues. Using chicks. Miller and White (1975) explored possible ef­
fects of three different antioxidants on tissue fatty acid patterns. 
Neither selenium, nor dl-a-tocopherol, nor ethoxyquin had any influence 
on the distribution of fatty acids. Donovan et (1977) fed rats 5% 
stripped lard or 5% stripped corn oil, supplemented with 0, 10.5, or 
105 mg/kg dl-a-tocopheryl acetate. All diets were EFA sufficient and sup­
plemented with sodium selena te. After three weeks diet and lung fatty 
acids were equilibrated. Although the source of dietary fat altered 
relative concentrations of pulmonary fatty acids, dl-a-tocopheryl acetate 
supplementation had no effect. Recent work by these same authors 
duplicated the results in another species. Vitamin E, whether sup­
plemented at 0, 10.5, or 105 mg/kg diet, had no significant effect on 
mouse lung fatty acid composition (Donovan and Menzel 1979). Observa­
tions of the fatty acid patterns of platelets established lack of a 
relationship between the levels of a-tocopherol and individual FAs 
(Schoene and Lehmann 1978). A rise in C20:4u)6 and a decline in C18:2uj6 
on a vitamin E deficient diet was apparent in rabbit muscle but less 
obvious in heart, liver, lung, or kidney (Chan et £l. 1978). A possible 
explanation for these inconsistencies came from research by Farnsworth 
et al. (1979). They studied the effects of vitamin E and selenium 
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deficiencies on the fatty acid composition of rat retinal tissues. 
A dietary deficiency of either antioxidant caused a large decrease in 
the total PUFA of rat retinal pigment epithelium with slight increases 
in C18:2iJ6 and 020:41)6. In contrast, there were no changes in the whole 
retina. Thus, fatty acid compositional alterations were not generalized 
to all tissues when changing antioxidant intakes. 
In contrast to fatty acids, tissue tocopherol levels were more 
clearly related to dietary tocopherol. Lehmann ^  al. (1977a) fed human 
volunteers 7.6 mg a-tocopherol/day for 40 days followed by 12.9 mg 
a-tocopherol/day for 40 days. In both females and males the plasma 
tocopherol levels rose in response to the dietary increase. However, 
the dietary fat also increased and plasma total lipids increased which 
has been shown to influence plasma tocopherol. Realizing that assess­
ment of vitamin E status using plasma is complicated by plasma total 
lipid levels, Lehmann (1978) then measured only platelet tocopherol. 
She reported a logarithmic relationship between dietary and platelet 
tocopherol and no relation between platelet tocopherol and plasma total 
lipids. Thus, this method was proposed as superior for assessment of 
vitamin E nutriture. Yang and Desai (1977b) showed a definite hepatic 
deposition of cc-tocopherol in response to increasing dietary tocopherol 
intakes. In contrast, pulmonary tocopherol increased only slightly when 
the tocopherol content of the diet increased (Aftergood and Alfin-Slater 
1978). 
Vitamin E appears linked to immunological functions. In the mouse 
vitamin E supported P-cell mitogenesis in spleen and lymph node (Shloss 
and Corwin 1977). In adult male rats fed 500 mg dl-a-tocopheryl acetate 
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three times weekly, the ability of mixed leukocytes to kill Staphylococcus 
aureus was totally eliminated. Excess vitamin E appeared to inhibit 
the oxygen-dependent free radical process involved in the bactericidal 
activity of leukocytes (Fong et al. 1978). Authors in India giving 
adult and young human males 300 mg dl-a-tocopheryl acetate/day for 
three weeks also found significantly depressed bactericidal activity 
by leukocytes and a depression in mitogen-induced lymphocyte transforma­
tion. A simultaneous in vivo test of skin hypersensitivity showed 
vitamin E had no effect. At the same time, one subject on vitamin E 
experienced complete relief of a nasal allergy and another had improve­
ment of asthmatic attacks (Prasad 1980). Thus, vitamin E had differential 
effects on different limbs of immune response. Corwin and Shloss (1979) 
reported vitamin E to be a mitogen acting on the immune response by a 
mechanism other than antioxidation. At suboptimal and at high levels 
vitamin E was more effective as a stimulant to the thymus-dependent 
lymphocyte response to conconavalin A than vitamin E at normal dose 
levels (Corwin and Shloss 1980). 
The connection between tocopherol and immunity may be through 
prostaglandins. Chickens fed a high vitamin E diet exhibited reduced 
mortality from an E. coli challenge as well as depressed PGE^, PGE^, 
and PGFg^ in spleen and in bursa (Likoff £t al. 1978). This suggested 
vitamin E enhanced the immune response by reducing PG production. 
Dietary vitamin E has been implicated in irregularities of plate­
let aggregation. A PUFA-rlch vitamin E-deficient diet fed to pigs was 
associated with pronounced platelet thrombosis (Nafstad 1974). Coagula­
tion could be induced in rats on either an a-tocopherol deficient diet 
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or a lipid rich diet. However, if the high lipid diet were supple­
mented with (Ï-tocopherol, the animals were protected (Fong 1976). 
Corrigan and Marcus (1974) reported a case study of a patient with de­
layed coagulation time who had been self-administering excessive doses 
of vitamin E. A 16-month-old infant with signs of vitamin E deficiency 
had abnormal aggregation (Khurshid et al. 1975). Platelet aggregation 
occurred with a biphasic response — the immediate phase and the second 
wave. Addition of a-tocopherol to the incubation medium did not affect 
the first phase but inhibited the second. This second phase could also 
be inhibited by indomethacin and acetylsalicylate sodium (Fong 1976). 
Not only crtocopherol but its nicotinate and acetate esters exerted 
inhibitory effects on arachidonate-induced platelet aggregation (Svensson 
and Oki 1978). As platelets aggregated, lipid peroxides were released. 
When a-tocopherol was added to the incubation medium at concentrations 
up to 1.5 mM, a dose-dependent reduction in platelet aggregation was 
noted. There was rapid uptake of a-tocopherol by platelets, and a 
linear relation was established between platelet and concentration of 
CÏ-tocopherol in the incubation medium. Alpha-tocopherol inhibited the 
second wave of aggregation and decreased lipid peroxide release from 
the platelets (Steiner and Anastasi 1976). However, in vitro incuba­
tion of platelets with vitamin E failed to inhibit the platelet lipoxy­
genase or depress ^^C-HETE synthesis from arachidonate (Gwebu et al. 
1978). 
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Vitamin E and PG synthesis 
The influence of vitamin E on immunity, lung protection, and plate­
let aggregation suggests a physiological role in PG metabolism. Many 
studies have hinted that PG synthesis is altered in vivo by vitamin E, 
though few actual measures have been taken. Lands et al. (1973) found 
that 500 pM cr-tocopherol inhibited PG synthesis by 50% and concluded 
that the inhibition was related to the structure of the enzyme (sheep 
vesicular gland oxygenase) and not the antioxidant ability alone. 
Although o^tocopherol added to the incubation medium significantly 
inhibited soybean lipoxygenase, it had no effect on mammalian cyclooxy-
genase as measured by incorporation of label in product in a bovine 
vesicular gland microsomal system (Panganamala et 1977). Vitamin E 
at 1.0 mM to 5.0 mM failed to inhibit PG synthesis (Zenzer and Davis 
1978). Thus, results of the in vitro work are contradictory. 
Nearly all the in vivo investigations of the effect of vitamin E 
on PG synthesis have been conducted by one laboratory and have focused 
on vitamin E deficiency. Feeding a vitamin E deficient diet of 7% 
stripped lard and 3% stripped cod liver oil to rabbits, Chan et al. 
(1978) reported a metabolite of PGFg^ in plasma was higher in deficient 
than in control animals. Later, using a microsomal preparation from 
rabbit semitendinosus muscle, they found a significant depression in 
PGEg and PGFg^ which was restored to normal after supplementation with 
oral tocopherol (Chan et al. 1979). This depressed synthesis of prosta­
glandins, they felt, explained in part the observed elevations in muscle 
C20:4uj6 in vitamin E deficiency. Skeletal muscle cyclooxygenase normally 
produced PGE^ and PCFg^ in a 1:1 ratio. While vitamin E deficiency 
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significantly reduced the enzyme activity, the PGE^/PGF^^ ratio was un­
changed. Cyclooxygenase activity returned to normal within 48 hours of 
oral tocopherol supplementation (Chan £t 1980a). The key enzyme 
controlling PG catabolism is 15-hydroxy-prostaglandin dehydrogenase 
(PGDH). Vitamin E deficiency elevated activity of PGDH in skeletal 
muscles of rabbit but not in heart or kidney (Chan et al. 1980b). 
Prostaglandin synthesis was also depressed in testis during vitamin E 
deficiency (Thuy et 1978). In contrast, Hope et al. (1975) re­
ported PGE^, PGE^, and PCEg^ were elevated in serum from vitamin E 
deficient animals. 
Little work has been done on the effects of excessive vitamin E on PG 
synthesis in vivo. Likoff e^ £l. (1978) measured PGs in chickens which 
received normal and high vitamin E diets. Splenic PGE^, PGE^, and 
PGFg^ synthesis was inhibited by the high vitamin E diet. Hope et al. 
(1975) fed rats four different levels of «-tocopherol and measured serum 
PGs. There was an inverse dose-response. The higher the serum tocopherol 
level, the lower the level of PGEg and PGF^^. 
The evidence, both direct and indirect, suggests a relationship 
between vitamin E and PG synthesis. It remains to clarify the rela­
tionship, the effective doses and isomers, the responsive prostanoids, 
the mechanism, and the functional significance. 
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METHODS 
Experimental Design 
Animals in Experiment I were randomly assigned to control or EFAD 
groups. In Experiment II seventeen litters of four or five mates for a 
total of 80 rats were depleted of EFA for 45 days. Results from the 
first experiment showed that a 45-day depletion period would pro­
vide a population whose trienettetraene ratio was >0.4. Previous ex­
perience also indicated that a few animals would fail to grow uniformly 
or would develop diseases, or otherwise become unfit for continuance in 
an experiment. Therefore, from the 80 EFAD animals we were able to 
select a uniform population of 60 animals, 4 littermates from each of 15 
litters for application of the experimental treatments. In Experiment 
III 60 rats were depleted of EFA for 45 days. From this population 
40 animals were selected for continuation in the experiment. 
On the 46th experimental day animals were randomly assigned to one of the 
six experimental groups in Experiment II or four experimental groups in Experi­
ment III. Animals receiving 0, 1, 5, 10, 20, or 50 mg vitamin E supplementation/ 
day were designated 0-T, 1-T, 5-T, 10-T, 20-T, or 50-T, respectively. Figures 3 
and 4 detail the experimental design. Animals assigned to EFAD groups were 
killed on the 46th experimental day. Animals in groups 0-T through 50-T were 
lightly anesthetized with ether. A blood sample was taken from the orbital 
sinus. Each animal was then weighed and changed to a 20% saff lower oil diet (SO) 
and to one of the dl-crtocopheryl acetate supplements. Animals in groups 0-T 
through 50-T received the experimental treatment until the 91st experi­
mental day, at which time they were sacrificed. 
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«TOCOPHERYL ACETATE (MG/DAY) 
Figure 3. Design of Experiment II 
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Figure 4. Design of Experiment III 
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Purposes of Experiments 
Experiment I was undertaken to establish the length of time re­
quired to deplete body stores of EFA to a target point of serum T/T > 
0.4. We wished animals to remain in good health and to show only the 
commencement of EFA deficiency. Experiment II was designed to observe 
the effect of graded levels of a-tocopherol supplementation on growth, 
body weight, food efficiency, erythrocyte hemolysis, serum and pulmonary 
FA composition, and pulmonary a-tocopherol stores. The purpose of 
Experiment III was to replicate the results of Experiment II on selected 
dependent variables, to provide a further increase in dose of o^^ 
tocopherol to provoke a response, and to assay PG synthetic rate in 
lung and serum. 
Treatment of Animals 
All animals were weanling male Wistar rats from the stock colony 
of the Department of Food and Nutrition, Iowa State University. The 
animals were housed in individual 1/2-inch wire mesh cages in a room 
maintained at approximately 25° and 45-55% relative humidity. In 
Experiment I the animals experienced the following light-dark cycle: 
1100-2300 hours dark, 2300-1100 hours light. In Experiments II and 
III the photoperiod was shifted slightly so the animals experienced 
light from 0100 to 1300 hours and darkness from 1300 to 0100 hours 
daily. These hours were selected to permit the animals entrance into 
the dark cycle, their active time, just after feeding and watering 
activities were completed. In this way the animals experienced the least 
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disruption of their resting phase and had fresh food and vitamins 
available at the onset of their active phase. Animals were provided 
fresh food every other day, vitamin supplements daily, and clean 
cages and water bottles weekly. Water-soluble and fat-soluble vitamin 
supplements were given in small glass dishes. After a few days animals 
had learned to consume these quantitatively within a few minutes fol­
lowing administration. Food and distilled water were available ad libitum. 
The animals were weighed every other day. Food intake was determined 
every other day by collecting all spilled food and weighing it along 
with the uneaten food remaining in the diet jar. 
Diets and Supplements 
Composition of the essential fatty acid deficient (EFAD), control, 
and 20% safflower oil (SO) diets appears in Table 2. 
The water-soluble vitamin supplement was used throughout the course 
of all the experiments. All animals in all groups received 1.0 ml of 
the water-soluble vitamin supplement each day. Composition appears in 
Table 3. 
Fat-soluble supplements were measured into vitamin cups with 
calibrated droppers. Fat-soluble vitamin supplements were prepared by 
mixing weighed amounts of each vitamin in a small amount of appropriate 
oil. Oil was added to bring each supplement up to the weight pre­
determined to provide proper daily dosage by the calibrated dropper. 
Tables 4, 5, and 6 show the fat-soluble vitamin supplements used in 
Experiment I, Experiment II, and Experiment III, respectively. To 
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Table 2. Composition of essential fatty acid 
and 20% safflower oil (SO) diets 
deficient (EFAD), control, 
% bv weight 
Ingredient EFAD Control SO 
Casein, vitamin 
free, test^ 26.0 26.0 26.0 
dl-methlonine^ 0.39 0.39 0.39 
Williams-Briggs modified 
mineral mix'^ 3.5 3,5 3.5 
Nonnutrltlve fiber^ 2.0 2.0 2.0 
Hydrogenated coconut oll^ 20.0 18.0 — 
Corn oll^ — 2.0 — 
Safflower oil^ — — 20,0 
Cornstarch® 48.11 48.11 48.11 
^U.S. Biochemical Corp., Cleveland, Ohio. 
^Grand Island Biological Co., Grand Island, New York. 
^Williams et al. (1968), Teklad Test Diets, Madison, Wisconsin. 
^Teklad Test Diets, Madison, Wisconsin. 
®Mazola, Best Foods, CPC International, Englewood Cliffs, New 
Jersey. 
^Pacific Vegetable Oils International, Richmond, California. 
^Clinton Corn Processing, Clinton, Iowa. 
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Table 3. Composition of water-soluble vitamin supplement 
Ingredient Dose/rat/day 
Thiamine HCl^ 29 Hg 
Riboflavin^ 39 MS 
Pyridoxine HCl^ 20 |Jg 
Folic acid^ 20 ng 
D-Ca-pantothenate^ 97 Hg 
p-amino-benzoic acid^ 97 pg 
Vitamin 0.2 pg 
Biotin^ 2.0 Mg 
Niacin^ 64 Mg 
i-Inositol* 2,4 mg 
Choline Cl^ 4.8 mg 
20% ethanol 1.0 ml 
^Grand Island Biological Co., Grand Island, New York. 
^ICN Pharmaceuticals, Inc., Cleveland, Ohio, 
^General Biochemicals, Inc., Chagrin Falls, Ohio (known as Teklad, 
Madison, Wisconsin, since 1975). 
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Table 4. Composition of fat-soluble vitamin supplement for Experi­
ment I and for all EFAD groups 
Ingredient Dose/rat/day 
Vitamin 
dl-cy-tocopheryl acetate^ 
Retinyl palmitate^ 
Vitamin 
Tricaprylin^ 
10 pg 
1.0 mg 
17 
0.6 Mg 
34-44 mg^ 
Sigma Chemical Co., St. Louis, Missouri. 
^Teklad Test Diets, Madison, Wisconsin. 
'Grand Island Biological Co., Grand Island, New York. 
^Nutritional Biochemicals, Cleveland, Ohio. 
'Weight appropriate to calibration of dropper. 
avoid administering EFA, we used tricaprylin as carrier for fat-
soluble vitamins in EFAD. 
Food Efficiency Ratios 
Food efficiency ratios were calculated by dividing food intake for 
the period by weight gained during the period. 
ppR _ food intake (g) 
weight gain (g) 
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Table 5. Composition of fat-soluble vitamin supplements for Experi­
ment II 
Dose/rat/day 
Ingredient 0-T 1-T 5-T 10 -T 20 -T 
Vitamin 10 PS 10 Mg 10 Mg 10 Mg 10 Mg 
dl- (y-tocopheryl acetate^ 1.0 mg 5.0 mg 10. 0 mg 20. 0 mg 
Retinyl palmitate^ 17 Mg 17 Mg 17 Mg 17 Mg 17 Mg 
Vitamin 0.6 ' Mg 0.6 Mg 0.6 Mg 0.6 Mg 0.6 M-g 
Corn oil*^ 40 d mg 39 d mg 35 d mg 40 d mg 30 d mg 
^Grand Island Biological Co., Grand Island, New York. 
^Teklad Test Diets, Madison, Wisconsin. 
^Mazola, Best Foods, CPC International, Englewood Cliffs, New 
Jersey. 
^Weight appropriate to calibrated dropper used. 
Nonterminal Blood Sampling 
In Experiment I blood samples were taken from four control animals 
and 11 EFÂD animals on experimental day 22. Blood samples were taken 
from groups 0-T through 50-T in Experiments II and III on experimental 
day 46. Each animal was lightly anesthetized with ether. A 100 Hi 
glass capillary tube was carefully inserted behind the right eye into 
the orbital sinus, and An average of 1.2 ml whole blood was drawn into 
a graduated glass centrifuge tube chilled in an ice bath. Bleeding was 
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Table 6. Composition of fat-soluble vitamin supplements for Experi­
ment III 
Dose/rat/dav 
Ingredient 0-T 1-T 50-T 
Vitamin 10 Mg 10 10 Mg 
dl-a-tocopheryl acetate^ 1.0 mg 50.0 mg 
Retinyl palmitate^ 17 m 17 Pfi 17 Pg 
Vitamin 0.6 ' VB 0.6 Mg 0.6 Mg 
Corn oil^ 55 d mg 64 d mg 100 mg^ 
^Grand Island Biological Co., Grand Island, New York. 
^Teklad Test Diets, Madison, Wisconsin. 
^Mazola, Best Foods, CPC International, Englewood Cliffs, New 
Jersey. 
height appropriate to calibrated dropper used. 
stopped at once by applying pressure to a cool moist cottonball over the 
eye. Blood was centifuged at 600 x g for 20 minutes at 4°. Serum was 
transferred to one-dram vials, flushed with nitrogen, and stored at 
-20° awaiting further analysis. 
Necropsy 
All the animals of Experiment I and all EFAD animals of Experiments 
II and III were killed on experimental day 46. The remaining rats were 
killed on experimental day 91. All were allowed to eat until 
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sacrifice by cervical dislocation^. 
Blood was taken immediately by heart puncture in the left ventricle. 
In Experiment I all the blood was placed in covered centrifuge tubes 
in an ice bath, and held po more than 30 minutes before further 
processing. Whole blood was centrifuged at ,600x g for 20 minutes at 4°. 
The serum was transferred to one-dram vials, layered with nitrogen, and 
stored at -20o until further analysis. In Experiment II one drop whole 
blood was added to 3.0 ml saline-phosphate buffer at room temperature 
for hemolysis determination and was held at room temperature no longer 
than 30 minutes before continuing the hemolysis analysis. The remaining 
blood was handled as in Experiment I. In Experiment III one ml of 
blood was placed in a cooled glass centrifuge tube and treated as in 
Experiment I. The remaining blood was immediately incubated at 37° 
for 10 minutes for PG analysis. At the end of incubation a 0.1 volume 
of 4.2 mM solution of aspirin in KPi buffer (pH 7.4) was added and the 
tube cooled in ice and centrifuged at 600x g for 20 minutes at 4°. 
Serum was transferred to a one-dram vial and stored at -20°. 
In all three experiments lungs were excised, weighed, immediately 
frozen in liquid nitrogen, sealed in plastic pouches, and stored at -20° 
until further analysis. In Experiment III the left lung was handled 
separately. Immediately upon removal the left lung was weighed, and 
2 homogenized in 5.0 ml cold KPi buffer with a Brinkman polytron PCU-2-110 
at rheostat setting 5.5 for 60 seconds. The homogenate was incubated in 
^Cervical Dislocators, Inc., Wausau, Wisconsin, 
brinkman Instruments, Westbury, New York. 
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a shaking water bath at 37° for ten minutes. At the end of incubation 
2.5 ml of 42 mM aspirin in KPi buffer (pH 7.4) was added and the mixture 
stored at -20°. 
Chemical Analyses 
Lipid extraction 
Total serum lipid was extracted by the method of Sperry and Brand 
(1955), using 0.5 ml serum. The resultant extract was made up to a 5.0 ml 
volume in dry chloroform and stored under Ng at -20°. Total lung lipids 
were extracted by the method of Folch et al. (1957) , brought up to a 
5.0 ml volume in dry chloroform, and stored under N, at -20°. 
Methylation 
Both serum and lung lipid extracts were methylated by placing a 
2.0 ml aliquot of the extract in a screw-capped culture tube. Extract 
was evaporated to dryness at room temperature under a stream of nitrogen. 
Immediately 1.0 ml benzene, 1.0 ml methanol, and 1.0 ml 14% BFg-methanol^ 
were added. Contents were mixed by shaking briefly. Tubes were flushed 
with nitrogen and closed tightly with teflon-lined screw caps. Tube 
contents were heated in a boiling water bath for 30 minutes. Methyl 
esters were extracted by adding two volumes (4 ml) hexane and one volume 
(2 ml) distilled water. Tube contents were thoroughly mixed for ten 
seconds, then centrifuged 10 minutes at 1100 x g until layers were clearly 
^Applied Science Laboratories, State College, Pennsylvania. 
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separated. The top layer was transferred to a 2-dram vial, flushed 
with nitrogen, capped, and stored at -20°. 
Gas chromatography 
The resultant fatty acid methyl esters were concentrated under 
nitrogen and warmed to room temperature before a 1.0 nl aliquot was in­
jected into a Beckman^ GC 72-5 flame ionization gas chromatograph equipped 
2 
with two columns. Peak areas were determined by an Infotronics Auto­
matic Digital Integrator Model CRS-208 on one column and a Columbia 
3 Scientific Industries Supergrator-1 Computing Integrator on the other. 
The columns themselves were 6-foot, stainless steel, 1/8-inch diameter, 
packed with W-AW support, 100-120 mesh, and 10% cyano silicone-10 
liquid phase^. Conditions of operation were as follows: columns 180°, 
detector 250°, inlets 55°, line 55°, nitrogen (carrier gas) flow rate 
20 ml/min, make-up gas flow rate 60 ml/min, flow rate 45 ml/min, air 
flow rate 300 ml/min, full-scale amps = 1 x 10 Correction factors 
were developed using standards of known composition. Fatty acids were 
identified by comparison of their retention times with those of known 
standards^. 
^Beckman Instruments, Inc., Fullerton, California. 
2 
Infotronics Corp., Austin, Texas, 
3 
Columbia Scientific Industries, Dallas, Texas. 
^Alltech Associates, Arlington Heights, Illinois. 
^Applied Science Laboratories, State College, Pennsylvania. 
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Hemolysis 
The method for determining hemolysis was that of Draper and 
Csallany (1969). The only modification in the method was a shortening 
of the incubation time from four to three-and-a-half hours. We found 
that precisely the same results could be obtained with the shorter 
incubation time. Absorbance of the sample was determined on a Beckman^ 
2 
DU Spectrophotometer, Model 2400, equipped with an Update Instrument 
Digital Display Readout. 
Alpha-tocopherol 
The CK-tocopherol content of lung was determined by a modification 
of Bieri's (1968) procedure. The frozen lung was rapidly minced with 
stainless steel scissors and a randomized sample of approximately 0.5 g 
was placed in a screw-capped glass test tube containing 1.5 ml 8% 
ascorbic acid in 5 mM Na^EDTA, and 1.0 ml redistilled ethanol. From 
this point on, all procedures were performed in a darkened room, the only 
light coming from the hallway through a frosted glass panel in the door. 
The tube contents were layered with nitrogen, capped, and placed in a 
65° water bath. After five minutes 1.0 ml saturated KOH solution (made 
by adding 15 g KOH to 11 ml deionized, distilled water) was added. 
The tube contents were layered with nitrogen, capped, and placed in the 
65° water bath for 20 additional minutes. Several times during digestion 
and saponification, the tube was briefly shaken. At the end of 20 minutes, 
the tissue fully digested, the tube was placed in an ice bath. When 
^Beckman Instruments, Inc., Fullerton, California. 
Instruments, Madison, Wisconsin 
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cooled, the saponified mixture was extracted with 4.0 ml redistilled 
hexane three times for a pooled extract total of 12 ml. Three ml aliquots 
were transferred in duplicate to 15 ml ground glass-stoppered centrifuge 
tubes and evaporated to dryness under nitrogen at room temperature. The 
walls of the tube were washed down with progressively smaller volumes of 
benzene three times until all product was concentrated in the tip of 
the tube. This concentrate was quantitatively applied under a stream of 
nitrogen to a 20 cm by 20 cm glass plate. The plate was coated with a 
silica gel-sodium fluorescein solution of 250 microns thickness 
which was prepared by rapid mixing of 30 g silica gel and 60 ml of 
0.004% sodium fluorescein in distilled water. Plates were air dried 
one hour, placed in a 100° oven for two hours, and stored in a des-
sicator cabinet for use within two days. Immediately upon sample ap­
plication, the plate was placed in a solvent tank containing benzene: 
ethanol (150:3 v/v) for about 60 minutes. Upon removal, the plate was 
flushed with nitrogen, the of-tocopherol spot located by ultraviolet 
lamp, and the spot immediately scraped into a centrifuge tube. Two ml 
2 
of freshly prepared 0.02% bathophenanthroline in redistilled ethanol 
were added and the tube contents vigorously mixed 20 seconds. The tube 
was centrifuged two minutes at 1100x g and the supernatant decanted. 
The silica gel was eluted a second time and eluates pooled. All proce­
dures were performed under nitrogen, in the dark, as rapidly as possible 
to prevent ck^tocopherol oxidation. A two ml aliquot of eluate was 
^Brinkman Instruments, Westbury, New York. 
2 
G. Frederick Smith Chemical Co., Columbus, Ohio. 
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placed in a cuvette and 200 yl freshly prepared 0.03% FeCl^ in redis­
tilled ethanol added. Absorbance of the reaction mixture, briefly 
stirred, was read at 534 nm after two minutes. All samples were 
analyzed on a Beckman^ DU Spectrophotometer, Model 2400, equipped with 
2 
an Update Instrument Digital Display Readout. Alpha-tocopherol content 
of the cuvette was determined by reference to a standard curve, and 
Of-tocopherol content of the tissue was calculated. 
Measurement of pros taglandins 
The level of prostaglandins present in serum and in lung homogenate 
after a ten-minute incubation period was determined by radioimmunoassay 
as described by McCosh et aX. (1976). The specific antisera, normal 
rabbit serum (NRS), and anti-rabbit gamma globulin (ARGG) used in the 
assays are described in the Appendix (Table 27) . Compositions of the 
three buffers used appear in the Appendix (Tables 28, 29, and 30). 
Range-finding experiments demonstrated the dilutions necessary to 
place the tissue and serum samples within the range of sensitivity of 
the assay. Accordingly, all serum samples were diluted 1:4 in PBS gel 
and pulmonary homogenates were diluted 1:100 or 1:10 in PBS gel. 
On the first day of each assay the appropriate antiserum (anti-
PGE^, anti-PGEg, etc.) was diluted with normal rabbit serum to a pre­
determined, appropriate titer for the assay. Working dilutions of ARGG 
and NRS were mixed in a 1:1 ratio while the diluted antiserum and ARGG 
were also mixed in a 1:1 ratio. Both solutions were then allowed to 
^Beckman Instruments, Inc., Fullerton, California. 
2 Update Instruments, Madison, Wisconsin. 
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pre-precipitate overnight (or 6-24 hours) at 4°. Appropriate dilutions 
of reagents varied and were determined for each batch. 
After the pre-precipitation incubation period each diluted sample 
was assayed in duplicate and two standard curves were determined con­
currently with each assay set. Tubes were included in each assay to 
determine total counts/tube, background binding by NRS, and binding 
capacity of the antiserum. Assays were always conducted over ice and 
all reagents maintained at 4°. Each assay tube was prepared with 
sequential additions of PBS-gel, sample or standard, antiserum, and 
labelled prostaglandin. A representative protocol appears in the 
Appendix, Table 31. The tubes were shaken gently, wrapped tightly with 
parafilm, placed in a closed plastic bag and incubated at 4° for 12-36 
hours. After incubation each tube received 3.0 ml cold PBS and was 
centrifuged immediately at 8° at 2000 xg for 30 minutes. Supernatant 
was poured off and discarded. To the pellet was added 0.3 ml deionized, 
distilled water and 3.5 ml liquid scintillation counting cocktail^. Each 
2 tube was capped, briefly mixed and counted in a Packard Tri-Garb Liquid 
Scintillation Spectrometer, C2425, in the % mode, for either 10minutes or 
10,000 cpm, giving an error of usually 2.0% or less. The data were analyzed 
by the radioimmunoassay computer program designed by Duddleson et al. 
(1972) to provide concentrations per ml original homogenate or serum 
for each sample. Corrections for cross reactivity were made using simul­
taneous equations as proposed by McCosh et aj^. (1976). The fractional 
^Scintiverse, Fisher Scientific Co., Fairlawn, New Jersey. 
Packard Instrument Co., Downer's Grove, Illinois. 
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binding of PGE^ with PGE^-antiserum was 0.20 and PGE^ with PGEg-anti-
serum was 0.17. 
Statistical Analyses 
Treatment means, standard error of the means, t tests, analysis of 
variance, and linear regression were calculated via SAS computer pro­
gramming. In Experiment II a randomized balanced incomplete block 
design was employed as described by Cochran and Cox (1957). See Appendix, 
Table 32. In Experiment III animals were placed in treatment groups 
according to a randomized complete block design. In both cases by 
analysis of variance assuming a linear model, we were able to separate 
genetic effects from treatment effects. A standard of P < .05 was 
applied to identify significant differences among groups. In Experi­
ment II analysis of variance using both five and six group comparisons 
were made. In Experiment III analysis of variance using both three and 
four group comparisons were made. The six and four group comparisons 
permitted analysis of the effect of EFAD on dependent variables. The 
five and three group comparisons removed the effect of age differences 
and allowed straight comparison of o?-tocopherol affects. 
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RESULTS 
Analysis of variance (ANOVA) was performed on all dependent 
variables in Experiments II and III. Two types of analyses were run — 
one including and one excluding the EFAD group. Inclusion of the EFAD 
group allowed determination of the effect of fat source (FS) on de­
pendent variables. Exclusion of the EFAD group permitted determination 
of the effect of Qf-tocopheryl acetate (T) on dependent variables. Where 
ANOVA indicated possible group differences, t-tests were conducted to 
isolate the specific groups affected. 
Feeding graded levels of dl-a-tocopheryl acetate with 20% safflower 
oil resulted in few statistically significant differences among groups. 
In the following presentation of results, therefore, differences will 
be indicated only when statistically significant or suggestive. 
Experiment I 
Body weight and food intake 
Mean body weights were calculated at two time points during the 
experiment — after 19 and after 45 days on the diets. After 19 days 
the EFAD group weighed 135 + 3g and the control 139 + 9g. After 45 
days the EFAD group averaged 301 + 8g and the control group 322 + llg 
(Table 7). The EFAD group weighed slightly, but not significantly, 
less. 
Weight gains over the first 19 days of experimental feeding were 
87 + Sg for the control group and 84 + 3g for the EFAD group. Weight 
gains for the succeeding period (experimental days 20 to 46) were 183 + 3g 
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Table 7. Body weights, weight gains, food intakes and food efficiency 
ratios. Experiment I 
Control EFAD 
(n =4) (n = 11) 
Body weight (g) 
19 day _ 
46 day 322 + 11 301 ± 8 
139 ±9^ 135+3 
Weight gain (g) 
Days 1-19 87 + 8 84 +3 
Days 20-46 183 +3 166+7 
Total food intake (g) 537 + 19 517 + 13 
FER 0.50 + 0.01 0.48 + 0.03 
^Mean + SEM. 
for the control group and 166 + 7g for the EFAD group (Table 7). 
Total food intake for the control group was 537 + 19g and for the 
EFAD group 517 + 13g. Calculated food efficiency ratios were 0,50 + 0.01 
and 0.48 + 0.03 for control and EFAD groups, respectively (Table 7). 
Serum fatty acid profile 
Fatty acid patterns were determined on serum samples taken at two 
time points during the experiment in order to monitor progress of the 
development of EFA deficiency. 
After 21 days sharp differences were beginning to appear between 
EFAD and control animals. On the EFAD diet serum palmltate, palmitoleate, 
stearate, oleate, and eicosatrienoate rose while linoleate and arachldonate 
declined. The saturated and monounsaturated fatty acids and their 
metabolic products became more pronounced gs the levels of essential 
fatty acids dropped (Figure 5). Palmltate levels in control and EFAD 
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Figure 5. Serum fatty acid patterns after 21 and 45 days of feeding 
control or essential fatty acid deficient diets. Experi­
ment I 
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groups were 18.22 + 0.38% and 22.44 + 0.73% (p < .05). The differences 
between the two groups in level of stearate, oleate, linoleate and 
arachidonate were significant at p < .01. Oleate in control and EFAD 
groups was 10.19 + 0.38% and 20.02 + 0.36%, respectively. Arachidonate 
after only 21 days of EFA deficient diet was half of control levels, 
16.71 + 1.09% vs 35.75 + 3.57%. Eicosatrienoate, undetectable in the 
control group, was 4.42 + 0.80% in the EFAD group (p < .05, Table 8). 
Table 8. Serum fatty acid patterns after 21 and 45 days of feeding 
control or essential fatty acid deficient diets. Experi­
ment I 
% of total fatty acids measured 
21 days 45 days 
Fatty acid Control EFAD Control EFAD 
16:0 18.22 ± 0.38* 22.44 + 0.73* 22.07 ± 0. 44 26.14 + 0.85* 
16:1 0 1.72 + 0.30* 1.25 ± 0. 24 1.93 ± 0.49 
18:0 19.53 + 0.62 22.59 t 0.45** 22.18 ± 0. 46 22.51 + 0.78 
18:1 10.19 t 0.38 20.02 + 0.36** 12.17 ± 0. 75 23.52 + 0.73** 
18:2w6 16.32 t 2.20 12.08 + 0.50** 17.01 + 0. 31 10.08 + 0.69** 
20:3w9 0 4.42 t 0.80* 0 5.38 + 0.30** 
20:4w6 35.75 ± 3.57 16.71 + 1.09** 25.32 + 0. 60 10.45 + 0.73** 
T/T 0 0.: 26 0 0.51 
^Mean + SEM. 
*t, p < .05. 
**t, p < .01. 
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After 45 days a similar pattern with minor differences appeared. 
Falmltate, oleate, and elcosatrlenoate were significantly higher In 
the EFAD animais than In controls, and llnoleate and arachldonate levels 
were depressed. Llnoleate level was 17.01 + 0.31% In the control group 
and 10.08 + 0.69% In the EFAD group (p < .01). The level of arachldonate 
In the control vs EFAD animals was 25.32 + 0.60% vs 10.45 + 0.73% 
(p < .01, Table 8). Differences In palmltoleate and stearate levels 
in the two groups disappeared. The extent of depression of EFA levels 
after 45 days was somewhat greater than after 21 days, although the 
characteristic EFA deficiency pattern was clearly established after only 
21 days of EFA depletion. No C20:3cu9 was detectable in EFA sufficient 
animals, while the level rose in EFAD animals as the depletion continued. 
T/T ratio 
Triene:tetraene ratios for control animals were zero at both time 
points because no elcosatrlenoate was detectable. After 21 days the 
T/T of the EFAD group was 0.26. After 45 days the T/T ratio had risen 
to 0.51. 
Subjective observations 
We observed no clinical signs of EFA deficiency. There was no 
difference in appearance of tall, skin, or hair of EFAD and control 
rats. 
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Experiment II 
Body weights, gains. and food intake 
Initial mean body weights among the groups at the commencement of 
the EFA depletion period ranged from 53 to 56g. At the end of the 
EFA depletion period animals were randomly assigned to experimental 
treatment groups. Analysis of variance confirmed no significant dif­
ferences in body weight existed among groups. Mean body weights prior 
to application of the experimental dl-ovtocopheryl acetate doses ranged 
from 270 to 292g (Table 9). Final body weights were generally un­
responsive to (y- tocopheryl acetate dose (Figure 6). Final mean body 
weights of animals receiving 0, 1, 5, 10, or 20 mg dl-0(-tocopheryl 
acetate/day were 456, 445, 479, 436, and 458g, respectively (Table 9). 
Experimental weight gain ranged from 156 + 9 to 187 + 9g (Table 9). 
Food efficiency ratios declined with age from a mean of 0.467 during 
days 1 to 46 to a mean of 0.161 during days 80-91 (Table 9). 
Serum fatty acid patterns 
At the end of the EFA depletion period serum fatty acid patterns 
were similar among groups. Mean linoleate levels were 9.56% to 12.69% 
while T/T ratios were 0.47 to 0.82 (Table 10). The linoleate level and 
T/T ratio of the EFAD group of Experiment I fell within these ranges. 
Thus, the EFA depleted animals of Experiments I and II can be considered 
to be of the same population. 
Dietary supplements of dl-Of-tocopheryl acetate from 0 to 20 mg/day 
had no effect on the levels of individual fatty acids in total serum 
lipids (Table 11). Mean linoleate levels were 34.05% for the 1 mg 
Table 9. Body weights, weight gains, and food efficiency ratios. Experiment II 
Depletion 
period Experimental period 
Variable EFAD 0-T 1-T 5-T 10-T 20-T 
Initial body weight (g) 
(day 1) 54 + 1 56 + 1 55 + 1 56 + 1 53 + 1 54 +1 
Body weight at 
end of EFA depletion ^ g) 
(45 days) 283 + 3 281 + 3 277 + 3 292 + 3 280 + 3 270 +3 
Body weight at 
end of experimental 
period (g) 
(91 days) - 456 + 10 445 + 10 479 + 10 436 + 10 458 + 10 
Experimental period 
weight gain (g) 
(days 46-91) - 174 + 9 168 + 9 187 + 9 156 + 9 187 + 9 
Depletion period 
FER 
(days 1-45) 0.462 0.462 0.479 0.471 0.466 0.462 
Early experimental 
FER 
(days 46-61) - 0.402 0.372 0.376 0.330 0.405 
Middle experimental 
FER 
(days 62-79) - 0.266 0.259 0.263 0.246 0.254 
^Mean + SEM. 
Table 9. Continued 
Depletion 
period Experimental period 
Variable EFAD 0-T 1-T 5-T 10-T 20-% 
Late experimental 
FER 
(days 80-91) - 0.156 0.152 0.181 0.132 0.186 
ANOVA indicated no significant differences due to supplemental level of dl-a-tocopheryl 
acetate. 
Results of t-test: Experimental period weight gain, p < .10, group 10-T vs 20-T. 
70 
500 
/S 
o 
^ 450 
X (9 
W 
> 400 
- 91 DAYS 
79 DAYS 
X 
o 
o 350 
m 
61 DAYS 
300J 
5 20 
oi TOCOPHERYL ACETATE 
(M6/DAY) 
Figure 6. Dose-response curve of body weight at five a-tocopheryl 
acetate levels. Experiment II 
Table 10. Serum fatty acid profiles at end of depletion period. Experiment II 
Fatty % of total fatty acids measured 
acid EFAD 0-T 1-T 5-T 10-T 20-T 
16:0 23.16 + 0.89^ 25.03 ± 1.03 26. 70 ± 1.03 23. 70 ± 1. 03 24.07 + 1. 03 26.34 + 1.03 
16:1 3.38 ± 0.45 2.90 ± 0.47 2. 96 + 0.47 2. 99 ± 0. 47 2.36 + 0. 47 2.86 + 0.47 
18:0 22.53 ± 1.08 21.45 ± 0.97 23. 20 + 0,97 23. 21 ± 0. 97 24.69 + 0. 97 22,91 + 0.97 
18:1 21.56 ± 0.91 20.44 ± 1.00 21. 31 + 1.00 20. 74 + 1. 00 18.81 + 1. 00 21,73 + 1,00 
18:2w6 10.46 + 0.81 10.83 ± 1.05 9. 56 + 1.05 11. 59 ± 1. 05 12.69 + 1. 05 10.39 ± 1.05 
18:3(u3 Trace Trace Trace Trace Trace Trace 
20;3cu9 6.05 + 0.67 7.31 + 0.66 6. 67 + 0.66 6. 70 + 0. 66 5.30 + 0. 66 6,05 + 0.66 
20:4w6 12.84 + 1.30 12.05 + 1.28 9. 59 ± 1.28 11. 06 + 1. 28 12.09 + 1. 28 9.70 + 1,28 
T/T 0.50 ± 0.11 0.59 ± 0.11 0. 82 + 0.11 0. 61 ± 0. 11 0.47 + 0. 11 0,67 ± 0.11 
ANOVA including all six groups showed no significant differences. 
^Mean + S EM. 
Table 11. Serum total lipid fatty acid profiles at conclusion of Experiment II 
% of total fatty acids measured 
Depletion Experimental 
Fatty period period 
acid EFAD 0-T 1-T 5-T 10-T 20-T 
16:0 23.16 + 0.89® 14.65 + 0.98 15.08 + 0.98 14.91 ± 0.98 13.74 ± 0.98 14.96 ± 0.98 
16:1 3.38 + 0.45 0.04 + 0.01 0.06 + 0.01 0.04 + 0.01 0.05 + 0.01 0.05 + 0.01 
18:0 22.53 + 1.08 11.64 + 0.76 12.41 + 0.76 12.24 + 0.76 11.77 ± 0.76 11.89 + 0.76 
18:1 21.56 + 0.91 6.45 + 0.93 6.41 + 0.93 7.03 + 0.93 6.11 + 0.93 5.57 + 0.93 
18:2aj6 10.46 + 0.81 36.13 + 2.73 34,05 + 2.73 32.55 ± 2.73 36.89 + 2.73 33.95 + 2.73 
18:3m3 Trace 0.05 + 0.02 0.02 + 0.02 0 0 0 
20:3w9 6.05 + 0.67 0.17 ± 0.06 0.07 ± 0.03 0.13 + 0.06 0.24 + 0.10 0.15 + 0.06 
20Î4uj6 12.84 + 1.30 30.88 + 2.29 31.92 + 2.29 33.08 + 2.29 31.21 + 2.29 33.44 + 2.29 
T/T 0.50 + 0.11 0.01 0 0 0.01 0 
ANOVA showed no significant differences due to ortocopheryl acetate supplementation. 
®Mean + SEM. 
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dl-Qf-tocopheryl acetate group and 33.95% for the 20 mg group. Mean 
arachidonate levels were 31.92% for the 1 mg group and 33.44% for the 
20 mg group (Table 11). 
Refeedlng the EFA depleted animals with 20% SO lowered saturated 
and u)9 unsaturated fatty acids. Linoleate and arachidonate were in­
creased threefold by SO refeeding (Table 11). Linoleate in the EFAD 
group was 10.46 + 0.81% and in the 1-T group was 34.05 + 2.73%. 
Arachidonate in the EFAD group was 12.84 + 1.30% and in the 1-T group 
was 31.92 + 2.29% (Table 11). 
Pulmonary fattv acid profile 
After EFA depletion C18:2w6 was 2.40 + 1.18% and C20;4u)6 was 
10.48 + 0.66% in lung (Table 12). Following refeeding with SO 
fatty acid composition of lung changed considerably, but values were 
not different due to dose level of crtocopheryl acetate (Table 12). 
The 1-T and 20-T groups had 31.81 + 1.98% and 30.93 + 1.98% linoleate, 
respectively, and 13.59 + 0.89% and 13.74 + 0.89% arachidonate. 
T/T ratios 
At the end of the 45-day EFA depletion period serum T/T was greater 
than 0.4 in all groups, ranging from 0.82 + 0.11 to 0.47 + 0.11 (Table 10). 
After the 45-day refeeding period with 20% SO and five levels of dl-o^ 
tocopheryl acetate all groups had normal T/T ratios in serum and pul­
monary total lipids (Tables 11 and 12). The T/T ratios after feeding 
safflower oil and vitamin E ranged from 0.09 in lung to 0 in serum, 
similar to the 0 ratio in the control group of Experiment I (Table 13). 
Table 12. Pulmonary total lipid fatty acid profile. Experiment II 
% of total fatty acids measured 
Depletion Experimental period 
Fatty period 0-T 1-T 5-T 10-T 20-T ANOVA 
acid EFAD FS T 
16:0 42.90+0.98® 30.93 + 1. 18 30. 25 ± 1. 18 31. 93 + 1. 18 32. 52 + 1. 18 30.92 + 1.18 P < .01 
16:1 1.33+0.72 0.12 + 0. 52 0. 15 ± 0. 52 0. 28 + 0. 52 0. 21 + 0. 52 0.30 + 0.52 
18:0 12.29±0.46 10.85 + 0. 55 10. 06 + 0. 55 10. 29 + 0. 55 10. 74 + 0. 55 10.35 + 0.55 
18:1 29.17+1.01 13.12 + 0. 70 13. 60 + 0. 70 13. 84 + 0. 70 13. 96 + 0. 70 13.37 + 0.70 P < .01 
18:2(1)6 2.40+0.28 30.67 ± 1. 98 31. 81 ± 1. 98 32. 43 + 1. 98 28. 96 + 1. 98 30.93 + 1.98 P < .01 
18:3w3 Trace Trace Trace Trace Trace Trace 
20;3u9 1.41+0.16 0.79 ± 0. 23 0. 55 ± 0. 23 0. 42 + 0. 23 0. 34 + 0. 23 0.36 + 0.23 P < .01 
20:4w6 10.48+0.66 13.51 + 0. 89 13. 59 ± 0. 89 13. 24 + 0. 89 13. 27 ± 0. 89 13.74 + 0.89 
T/T 0.14+0.02 0.09 + 0. 00 0. 04 + 0. 00 0. 03 + 0. 00 0. 03 + 0. 00 0.03 + 0.00 
^Mean + SEM. 
Table 13. T/T ratios in serum and lung at end of depletion and refeeding periods. Experiment II 
EFAD 0-T 1-T 5-T 10-T 20-T 
After 45-day depletion 
Serum 0.50 + 0.11 0.59 + 0.11 0.82 + 0.11 0.61 + 0.11 0.47 + 0.11 0.67 ± 0.11 
Lung 0.14+0.02 ~ — — — — 
After 45-day refeeding 
Serum — 0.01 0 0 0.01 0.01 
Lung - 0.09 + 0.03 0.04 + 0.03 0.03 + 0.03 0.03 + 0.03 0.03 + 0.03 
T/T ratio of serum of control group in Experiment I was 0. 
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Hemolysis 
In all experimental groups percent hemolysis was normal, ranging 
from 4.4 + 1.2% to 7.6 + 1.1% (Table 14). Even a presumptively 
deficient level of vitamin E (0 dietary supplementation) did not re­
sult in increased erythrocyte hemolysis (6.8 + 1.1%). No differences 
were seen at any a-tocopheryl acetate dose. 
Lung weight 
Animals in the 10-T group had smaller lungs than animals in other 
groups (Table 14). However, when lung weight was based on body weight 
(g lung/lOOg B.W.), there were no longer significant differences by ANOVA. 
Groups 1-T and 10-T differed significantly on a t-test (p < .01, 
Table 14). Values for lung weight per lOOg body weight ranged from 
0.41 + 0.02 for the lO-T group to 0.59 + 0.04 for the 1-T group. 
Pulmonary g- tocopherol 
Dietary or-tocopherol level was reflected in tissue «-tocopherol 
concentration. Accumulation of of-tocopherol in lungs of animals fed in­
creasing amounts of a-tocopheryl acetate was statistically significant 
(Table 14). Values in Mg or-tocopherol/g wet lung tissue were 46.7 + 4.7 
and 63.2+ 4.7 for groups 1-T and 20-T, respectively. A linear regres­
sion model fitting pulmonary a-tocopherol to dietary dl-of-tocopheryl 
2 
acetate was significant at p < .01, although the low r suggested a 
poor fit (Figure 7). 
Table 14. Erythrocyte hemolysis, pulmonary weight and a-tocopherol 
content. Experiment II 
Depletion Experimental period 
period 
EFAD 
0-T 1-T 
RBC hemolysis 
a) 4.4 + 1.2* 6.8 t 1.1 5.9 + 1.1 
Lung weight (g) 1.38 ± 0.08 2.11 ± 0.17 2.54 + 0.17 
g lung/lOOg 
body weight 0.49 ± 0.03 0.46 + 0.04 0.59 + 0.04 
Pulmonary of-
tocopherol 
(P^/g lung) 58.9 ± 3.8 49.2 ± 3.8 46.7 ± 3.8 
Results of t-test : 
Lung weight. 1-T vs 10-T, p < 
EFAD vs 1-T, p < 
.05. 
.05. 
Pulmonary a-tocopherol, 1-T vs 20-T, p < .05. 
g lung/lOOg body weight, 1-T vs 10 -T, p < .01, 
^Mean + SEM. 
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Experimental period 
5-T 10-T 20-T ANOVA 
FS T 
7.2 + 1.1 7.6 + 1.1 7.6 + 1.1 
2.30 + 0.17 1.78 + 0.09 2.26 + 0.23 p <.05 p < .05 
0.48 + 0.04 0.41 + 0.02 0.49 + 0.04 
59.0 + 3.8 55.3 + 3.8 63.2 + 3,8 < .05 
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Figure 7. Linear regression of pulmonary «-tocopherol on dietary 
a-tocopheryl acetate. Experiment II 
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Experiment III 
Body weights. gains, and food intake 
By design môan body weights of all groups at commencement and 
conclusion of EFA depletion period were similar to one another (Table 15) 
and to groups from Experiments I and II. 
During the experimental feeding of SO and graded levels of dl-œ-
tocopheryl acetate from 0 to 50 mg/day no differences in body weight 
appeared due to dose of vitamin E. The experimental time course was 
divided into early, middle, and late periods in order to monitor altering 
responses with progress of the experiment. At no time was there a 
statistically significant difference in body weight (Table 15). Weight 
gain during the late experimental period (days 83 to 91) tended to be 
reduced in the 50-T group, and total body weight showed a slight 
depression appearing only at the termination of the experiment (Figure 8). 
Final body weights ranged from 448 + lOg to 466 + lOg. 
A food efficiency ratio was determined only once during the experi­
ment, in the middle experimental period (days 76-82). Food efficiency 
ratios for the 0-T, 1-T, and 50-T groups were similar with values of 
0.138, 0.116, and 0.102, respectively (Table 15). 
Serum ^atty ayid pattern 
At the end of the EFA depletion period the EFAD group was signifi­
cantly different from the other groups in levels of palmitate and oleate 
(Table 16). The three groups to receive the experimental treatment, 
however, were uniform, with linoleate ranging from 5.38 + 0.55% to 
6.94 + 0.55%, eicosatrienoate 7.77 + 0.78% to 9.24 + 0.78%, and 
Table 15. Body weights, weight gains, and food efficiency. Experiment III 
Depletion 
period 
EFAD 
Experimental period 
0-T 1-T 50-T 
Initial body weight (g) 
(1 day) 51+1 
Body weight at end of 
EFA depletion (g) 
(45 days) 297 + 5 
Body weight at end 
of experimental 
period (g) 
(91 days) — 
Depletion period 
weight gain (g) 
(days 1-45) 245 + 4 
Experimental period 
weight gain (g) 
(days 46-91) — 
Early experimental 
weight gain (g) 
(days 46-76) — 
52 + 1 
303 + 5 
466 + 10 
251 + 4 
163 + 9 
131 + 6 
51 4- 1 
298 + 5 
458 + 10 
246 + 4 
161 + 9 
135 + 6 
52 + 1 
297 + 5 
448 + 10 
245 + 4 
151 + 9 
134 + 6 
00 
Mean + SEM. 
Table 15. Continued 
Depletion 
period Experimental period 
EFAD 0-T 1-T 50-T 
Middle experimental 
weight gain (g) 
(days 77-82) - 12 +3 11 +3 9+3 
Late experimental 
weight gain (g) 
(days 83-91) - 19 +2 15 +2 8+7 
FER 
(days 77-82) - 0.138 + 0.036 0.116 + 0.036 0.102 +0.036 
ANOVA indicated no differences among groups. 
83 
o< TOCOPHERYL ACETATE 
500 0 MG/DAY 
1 MG/DAY 
50 MG/DAY 
400 
— 300 
2200 
KK) 
91 76 46 
DAYS 
Figure 8. Body weights over time at three different doses of dl-a-
tocopheryl acetate. Experiment III 
84 
Table 16. Serum total lipid fatty acid profile at end of depletion 
period (after 45 days). Experiment III 
% of total fatty acids measured 
acid EFAD 0-T 1-T 50-T ANOVA 
16:0 29.77 ± 1.06* 26, 54 ± 1. 06 24.43 ± 1.06 25.36 ± 1.06 P < .05 
16:1 4.01 ± 0.67 3. 
+
1 
0. 67 2.22 ± 0.67 2.59 ± 0.67 
18:0 18.58 ± 0.91 17. 28 ± 0. 91 17.46 ± 0.91 16.53 + 0.91 
18:1 24.04 ±1.34 27. 38 + 1. 34 29.24 ± 1.34 29.43 + 1.34 P < .05 
18:2w6 7.04 ± 0.55 6. 94 + 0. 55 5.38 ± 0.55 6.00 ± 0.55 
18:3u)3 Trace Trac< > Trace Trace 
20;3m9 6.57 ± 0.78 7. 77 + 0. 78 9.34 + 0.78 8.24 ± 0.78 
20:4w6 9.98 + 0.91 10. 84 + 0. 91 12.05 + 0.91 11.86 + 0.91 
T/T 0.70 + 0.09 0. 75 ± 0. 08 0.83 + 0.08 0.71 ± 0.08 
ANOVA included all four groups. 
^Mean + SEM. 
arachidonate 10.84 + 0.91% to 12.05 + 0.91%. The T/T ratios showed all 
four groups uniformly EF^ deficient with T/T = 0.70, 0.75, 0.83, and 
0.71 (Table 16). 
Level of daily dietary supplementation with dl-cif-tocopheryl 
acetate was of no significant effect on serum total lipid fatty acid 
profile on the 91st experimental day (Table 17). However, group 50-T, 
which received 50 mg dl-ortocopheryl acetate/day, tended to have a 
reduced level of serum arachidonate. Group 1-T had 25.02 + 1.76% 
C20:4w6 while group 50-T had 18.75 + 1.76%. This difference approached 
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Table 17. Serum total lipid fatty acid profile at end of Experiment 
III 
% of total fatty acids measured 
Depletion Experimental period 
Fatty acid period 0-T 1-T 50-T 
16:0 29.77 + 1.06® 20.23 + 1.69 22.47 ± 1.69 20.74 + 1.69 
16:1 4.01 + 0.67 0.56 + 0.28 0.72 + 0.28 0.84 + 0.28 
18:0 18.58 ± 0.91 13.62 ± 1.02 14.78 ± 1.02 14.51 + 1.02 
18:1 24.04 ± 1.34 7.26 t 0.64 6.78 + 0.64 7.72 + 0.64 
18:2iu6 7.04 + 0.55 30.20 + 2.32 22.86 + 2.61 30.96 + 4.19 
20:3(ju9 6.57 ± 0.78 4.44 + 0.97 7.36 + 0.97 6.49 ± 0.97 
20:4UJ6 9.98 + 0.91 23.69 + 1.76 25.02 + 1.76 18.75 + 1.76 
T/T 0.70 + 0.09 0.20 ± 0.04 0.28 + 0.04 0.31 ± 0.04 
ANOVA indicated no significant differences due to a-tocopheryl acetate 
supplementation. 
^Mean + SEM. 
significance at p <.05. The t-test indicated no difference in C18:2u)6for 
groups 1-T and 50-T. The mean T/T ratio of the EFAD group was 0.70. The mean T/T 
ratio of the SO refed groups was 0. 26 jf 0.04 (Table 17) , higher than the 0.03 
in the SO refed groups of Experiment II (Table 12). 
Pulmonary fatty acid profile 
Levels of daily dietary vitamin E supplementation had no signifi­
cant effect on pulmonary total lipid fatty acid profile on the 91st 
experimental day (Table 18). Linoleate in group 1-T was 31.93 + 1.67% 
and in group 50-T 33.54 + 1.67%. Arachidonate in group 1-T was 
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Table 18. Pulmonary total lipid fatty acid profile. Experiment III 
% of total fatty acids measured 
Depletion Experimental period 
Fatty period 0-T 1-T 50-T ANOVA 
acid FS T 
p < .01 
p < .01 
p < .01 
p <.01 
p <.01 
p < .01 
^Mean + SEM. 
13.66 + 1.08% and in group 50-T 13.48 + 1.08%. The T/T ratios of the 
EFAD, 0-T, 1-T, and 50-T groups were 0.20, 0.06, 0.06, and 0.05, 
respectively. 
Another perspective on the distribution of fatty acids within the 
total lipids of a tissue is gained by calculation of ratios of selected 
fatty acids. VThile EFA deficiency was of significant effect in raising 
C18;l/C18;0, C20:4w6/C18:2w6, C20:3(d9/C20:4U)6 + C18:2UJ6 (T/T + D) 
in lung and serum, supplementation with oc-tocopheryl acetate had no 
effect on the pulmonary ratios (Table 19). Dietary a-tocopheryl acetate 
16:0 33.77 + 0.77 27.88 + 0.71 28.12 + 0.71 26.78 + 0.71 
16:1 6.37 ± 0.20 1.18 ± 0.19 0.92 + 0.19 0.90 ± 0.19 
18:0 14.71 ± 0.42 11.89 +0.39 11.63 + 0.39 11.36 + 0.39 
18:1 23.26 ± 0.54 12.54 + 0.44 12.91 ± 0.44 13.14 ± 0.44 
18:2oo6 3.72 ± 1.58 32.26 + 1.67 31.93 ± 1.67 33.54 ± 1.67 
18:3u)3 Trace Trace Trace Trace 
20:3da9 3.06 + 0.18 0.75 ± 0.06 0.79 ± 0.06 0.74 + 0.06 
20: 4u)6 14.94 + 1.00 13.39 ± 1.08 13.66 + 1.08 13.48 + 1.08 
T/T 0.20 0.06 0.06 0.05 
Table 19. Selected pulmonary and serum fatty acid ratios. Experiment III 
Depletion Experimental period 
period 0-T 1-T 50-T ANOVA 
BFAD FS T 
Lung 
C18:l/C18:0 1. 63 + 0.09® 1.11 ± 0.08 1.15 + 0.08 1. 18 ± 0.08 P < .01 
C20:Au)6/C18:2u6 5. 36 + 0.35 ' 0.46 + 0.06 0.50 + 0.06 0. , 42 + 0.06 P < .01 
C20;3iu9/C20:4UJ6 
+ C18:2u6 
(T/T + D) 0. 17 ± 0.01 0.02 + 0.0 0.02 + 0 0. 02 + 0 P < .01 
Serum 
C18:l/C18;0 1. 37 ± 0.10 0.56 + 0.08 0.49 + 0.08 0. 64 ± 0.08 P < .01 
C20;4u6/C18;2œ6 1. 53 + 0.14 0.88 + 0.10 1.21 + 0.10 0. 73 + 0.10 P < .01 p < .05 
C20:3US/C20:4uj6 
+ C18;2ii6 
(T/T + D) 0. 40 + 0.03 0.08 + 0.02 0.15 + 0.03 0. 14 + 0.02 P < .01 
*Mean + SEM. 
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significantly decreased the serum C20;4u)6/C18; 2(u6 ratio (p < .05). The 
serum (U6 ratios for groups 1-T and 50-T were 1.21 + 0.10 and 0.73 + 0.10 
(Table 19). 
Lung weight 
As in Experiment II, when lung weight was expressed relative to 
body weight, vitaminE treatment showed no effect (ANOVA) , The proportion of 
lung to lOOg body weight was similar in both experiments (Tables 14 
and 20). The proportional lung values for the 1-T and 50-T groups of 
Experiment III were 0.52 + 0.04 and 0.47 + 0.04 (Table 20). 
Pulmonary o?-tocopherol 
Pulmonary o-tocopherol tended to increase with additional a-
tocopheryl acetate in the diet, although the increase was not statisti­
cally significant. Concentrations of of-tocopherol in the lung for 
groups receiving 0, 1, or 50 mg dl-ortocopheryl acetate/day were 
54.4 + 3.7, 57.7 + 3.7, and 63.3 + 3.7 Mg/g lung, respectively 
(Table 20). Linear regression analysis revealed that although the 
data could be fitted to a straight line with positive slope, relating 
dietary and tissue crtocopherol, the slope of the line was not 
statistically different from zero (Figure 9). Thus, although there 
was an apparent trend toward pulmonary tocopherol accumulation, it 
was not significant. 
Serum prostaglandins 
The EFAD group had significantly reduced synthesis of PGE^ but 
not of PGEg or PGF^^ as compared to the SO refed groups. The average 
Table 20. Pulmonary weight and a-tocopherol content. Experiment III 
Depletion Experimental period 
period 0-T 1-T 50-T ANOVA 
EFAD FS 
Lung 
weight (g) 1.42 + 0.18 2.04 + 0.19 2.38 + 0.19 2.07 + 0.19 p < .01 
g lung/lOOg 
body weight 0.48 + 0,04 0.42 + 0.04 0.52 + 0.04 0.47 + 0.04 
tocopherol 
level 
(Mg/g lung) 67.8 + 4.9 54.4 + 3.7 57.7 + 3.7 63.3 + 3.7 
^Mean + S EM. 
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Figure 9. Linear regression model for pulmonary crtocopherol upon 
dietary or-tocophdry 1 acetate. Experiment III 
\ 
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PGEj^ value of the three experimental groups was twice that of the EFAD 
group. Mean PGE^ for group EFAD and group 0-T were 0.46 and 1.19 ng/ml 
(Table 21). Of the three PGs measured, PGFgQ, was present in the highest 
concentrations and PGE^ in the lowest in all groups. In group EFAD 
PGFgg was 9.66 + 2.61 ng/ml, PGE^ was 2.72 + 0.99 ng/ml, and PGE^ 
was 0.46 + 0.15 ng/ml. Comparison of groups 0-T, 1-T, and 50-T re­
vealed no differences in synthesis of PGE^, PGE^, or PGFg^ in incubated 
whole blood (Table 21). 
Pulmonary prostaglandin synthesis 
Essential FA deficiency did not reduce PG synthesis in pulmonary 
horaogenate. On the contrary, PGIg synthesis was significantly higher 
in lungs of the EFAD group than in groups 0-T, 1-T, and 50-T. Sup­
plementation with dl-o-tocopheryl acetate had no effect on PG synthesis 
in lung homogenate (Table 22). In groups 1-T and 50-T PGE^ was 
0.08 + 0.01 and 0.07 + 0.01 ng/mg, respectively. The levels of PGEg 
measured in groups 1-T and 50-T were 0.28 + 0.02 and 0.31 + 0.02 ng/mg. 
Prostaglandin F^^ in groups 1-T and 50-T was 7.61 + 0.94 and 7.58 + 
0.94 ng/mg lung. Prostacyclin in group 1-T was 1.84 + 0.16 and 
in group 50-T 1.86 + 0.16 ng/mg. The PGE^/PGE^ + PGFgg, ratio in lung 
was unaffected by dietary treatment (Table 22). Vitamin E supplementa­
tion did not alter the balance among PGs of the one and two series. 
Table 21. Prostaglandin synthesis in lO-minufce incubated arterial whole blood. Experiment III 
Depletion Experimental period 
period 0-T 1-T 50-T ANOVA 
EFAD FS T 
PGEi 
(ng/ml serum) 0.46 + 0.15* 1. 19 ± 0.15 0.69 ± 0.15 0.92 t 0.15 p < .05 
PGE2 
(ng/ml serum) 2.72 + 0.99 3. 73 + 0.99 5.50 + 0.99 4.41 + 0.99 
PGF2C 
(ng/ml serum) 9.66 + 2.61 14. 75 ± 2.61 14.23 ± 2.61 14.02 + 2.61 
PGEj^ 
PGEg + PGFga 
0.05 + 0.01 0. 10 + 0.03 0.07 + 0.01 0.06 + 0.01 
^Mean + SEM. 
Table 22. Prostaglandin synthesis in lO-minute incubated lung homogenate. Experiment III 
Depletion Experimental period 
period 0-T 1-T 50-T ANOVA 
EFAD FS T 
PGEi 
(ng/mg lung) 0.08 ± 0.01* 0.08 ± 0. 01 0.08 ± 0.01 0. 07 ± 0.01 
PGE2 
(ng/mg lung) 0.25 + 0.02 0.28 ± 0. 02 0.28 ± 0.02 0. 31 + 0.02 
PGF2a 
(ng/mg lung) 8.23 + 0.94 7.06 + 0. 94 7.61 ± 0.94 7. 58 + 0.94 
PGI2 
(ng/mg lung) 2.36 ± 0.16 1.65 ± 0. 16 1.84 + 0.16 1. 86 + 0.16 p < .05 
PGEi 
PGEg + PGFg^ 
0.01 0.02 0.01 0.01 
^Mean + SEM. 
94 
DISCUSSION 
Hypothesis 
Four disparate observations from past research form the basis for 
the present work. 
1. High PUFA diets may have deleterious effects. 
2. Level of dietary PUFA may influence PG synthesis. 
3. Vitamin E may inhibit PG synthesis in vitro. 
4. Vitamin E requirement is influenced by PUFA intake. 
Synthesis of these four ideas suggests that the deleterious effects of 
high PUFA diets may be mediated by altered PG synthesis coupled with a 
secondary vitamin E deficiency. An increase in dietary vitamin E might 
ameliorate the ill effects of high PUFA diets by moderating PG synthesis. 
The purpose of the present investigation was to test the interre­
lationship of dietary vitamin E, dietary linoleic acid, and prosta­
glandin synthesis. Alpha-tocopheryl acetate, one of the most stable 
forms of vitamin E, was used in vitamin supplements. A high dietary 
intake of safflower oil gave a rich source of linoleate. 
Model for Dietary Linoleate Research 
In order to observe the effects of dietary cy-tocopherol on in­
gested C18;2(u6 rather than on endogenous 018:2(1)6, I attempted to reduce 
the contribution of tissue to metabolic PUFA pools and maximize the 
contribution of diet. Animals were maintained on an EFA deficient diet 
for 45 days to deplete tissue stores of 18;2(u6. Reid et £l. (1968) 
estimated that a young rat, fed ^  libitum for 14 days, would have 
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10% of body weight as fat. This is admittedly a general figure, as 
composition of the diet, length of feeding period, and age of the rat would 
affect the value. Carlson and Arnrich (1978) estimated a 350g adult 
rat would have an average of 30% of body weight as lipid. According 
to their estimates, rats in this study weighing ca, SOOg at the end 
of the depletion period would have a body store of ca. 30-90g lipid. 
Although this fat is in various metabolic pools with varying turnover 
rates, one may use again the general rate of Reid et of 12% turnover/ 
day. Thus, 3-lOg fat is turning over daily. At the end of EFA depletion 
we found 10-12% linoleate in serum and 2-4% in lung. Coniglio 
et al. (1976) reported hepatic 18:2u)6 in EFA deficiency was 6.6% of 
total fatty acids. Using an average figure of 7% of body fat as 18:2u)6 
in EFA deficiency, the tissue contribution of metabolizable 18:2w6 was 
no more than 0.25-0.77g/day at the end of the depletion period. On a 
20% SO diet our rats were ingesting ca. 14g diet/day or 2.8g SO, which 
by our analysis contained 18:2m6 at 81% of total fatty acids. Thus, 
the dietary contribution of linoleate was 2.27g/day. At the commence­
ment of the experimental phase, when the dietary fat was changed from 
hydrogenated coconut oil (HCO) to safflower oil (SO), the dietary 
contribution of 18:2u)6 to labile pools was four to ten times the tissue 
contribution. Towards the end of the SO feeding regimen, body stores 
of 18:2(u6 were high. Linoleate was 35% of serum total lipids and 30% 
of pulmonary total lipids. By calculations, therefore, the tissue 
contribution of C18:2u)6 was estimated to be 1.l-3.8g/day. Dietary 
contribution of C18:2m6 to labile pools still rivalled tissue contribu­
tion. 
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Use of a 26% casein, 20% HCO diet produced biochemical but not 
clinical symptoms of EFA deficiency within 45 days. The EFA deficient 
rats appeared normal in all respects except in T/T ratio of serum total 
lipids. There was neither growth depression nor dermal abnormality in 
the EFA deficient rats. After only 22 days of an EFA deficient diet 
the T/T ratio of serum total lipids was already 0.26 as compared to 0 
for control animals. After 45 days the T/T ratio of serum total lipid 
was 0.51, just within the biochemical definition of EFA deficiency 
(>0.4). At the end of the 45-day EFA depletion period in Experiments 
II and III, the serum total lipid T/T ratios averaged 0.58 and 0.71, 
respectively. Three separate trials, depleting over 110 animals, 
demonstrated the efficacy and reproducibility of the EFA deficient 
diet to produce the desired population. 
Thus, it appears that a model for study of effects on dietary 
C18:2UJ6 has been successfully established. This model is composed 
of young rats who are indistinguishable from healthy control rats in all 
gross respects measured except in tissue stores of PUFA, The rats show 
no growth retardation, appetite depression, or dermal lesions that 
could complicate subsequent experimental treatments and measures. 
Effect of of-Tocopheryl Acetate on 
Body Weight, Growth, Food Efficiency 
Feeding a 20% by weight SO diet to weanling rats for 28 days has 
previously been associated with reduced growth rate and reduced energy 
efficiency (Higgins 1979). In Experiment II we found that levels of 
dietary a-tocopheryl acetate from 0 to 20 mg/day had no significant 
effect on body weight, weight gain, or food efficiency after 45 
days of feeding. - These rats, however, were older than those of Higgins 
when the dietary regimen with 20% SO was started. At an age of 111 
days the rats weighed on the average 450g in the second experiment 
and 457g in the third experiment. Replication between experiments 
indicated consistent, reliable results. When graded levels of a-
tocopheryl acetate (0, 1, 5, 10, and 20 mg/day) were administered, 
no clear trend of effect on body weight appeared. Final weights were 
randomly scattered about the mean with no relationship to treatment. 
When the a-tocopheryl acetate supplementation was increased to 50 mg/ 
day in the third experiment, the final body weights of the high-vitamin E 
group tended to be depressed compared to the low-vitamin E group 
(Table 14). Although the effect was not statistically significant, 
it was beginning to appear only in the final days of the experiment. 
This late-appearing trend to growth depression suggests (1) the level 
of vitamin E in question — 50 mg/day — may have approached a toxic 
dose, and (2) the experiment ended too soon. Corrick (1969) found 
growth depression in rats fed over 75 lU a-tocopherol/day for ten weeks. 
Conditions in the present study were moderate by comparison and gave less 
dramatic results. The high-vitamin E supplement of 50 mg/day was 
approximately 3570 mg/kg diet. This is nearly 100 times the estimated 
requirement of th# laboratory rat or mouse (National Research Council 
1978). Any nutrient, given at such levels, could be considered poten­
tially dangerous. It is possible the experiment ended before the effect 
was distinguishable. Future research might explore the long-tera 
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consequences of high-vitamin E supplementation. 
Body weight may mask subtle effects of diets and may be criticized, 
too, as a poor indicator of nutritive status (Morley 1976). A 
homogeneous population in regard to initial weight and depletion 
weight was used for further experimental applications. In the second 
experiment cx-tocopheryl acetate supplementation had no statistically 
significant effect on weight gain over the 45-day experimental period. 
Table 9 shows a scatter of gains and no clear trend with increasing 
dietary «-tocopherol. This suggests the reported weight gains are 
truly random, and a-tocopheryl acetate supplementation of 0 to 20 mg/ 
day did not modify weight gain. In the third experiment weight gain, 
although not statistically significant, appeared mildly depressed in the 
50 mg/day vitamin E group (Table 15). The division of overall weight 
gain into early, middle, and late periods suggests that the reduced 
growth rate, if genuine, came only late in the experiment. Again, one 
wonders lAat continuation of the feeding period might have revealed. 
The food efficiency ratio (FER) in Experiment III calculated during 
the middle experimental period (days 76-82), showed no statistically 
significant effect of dietary of-tocopheryl acetate, although as with 
body weight and weight gain, there was an apparent decline in FER with 
high vitamin E. As there was no significant depression in weight gain 
during the middle experimental period, the apparently reduced FER would 
be due to an increased food intake and decreased utilization. However, 
as no statistical evidence of experimental effect was evident, one 
must conclude that dietary vitamin E did not influence food efficiency. 
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Effect of Dietary a*-Tocopheryl Acetate on Hemolysis 
The percent of erythrocyte hemolysis is commonly used to assess 
vitamin E nutriture. Values of < 10% are considered to indicate 
adequacy of dietary vitamin E. The data indicate all six treatment 
groups had adequate a-tocopherol, and there was no increase in hemolysis 
with decreasing level of tocopherol supplementation (Table 14). The 
data indicate hemolysis to be an insensitive indicator of vitamin E 
intake. Severe deficiency would be signalled by this indicator, but 
subtle differences in a-tocopheryl acetate intake such as were em­
ployed in Experiment II are not reflected in hemolysis results. On 
the one hand, increasing levels of c^tocopheryl acetate above a 
moderate (1.0 mg/day) intake were not accompanied by changes in percent 
hemolysis. This suggests around 6% hemolysis is a background level, 
resistant to reduction or improvement. Thus, hemolysis is useless as 
an indicator of vitamin E intakes above adequate. We agree with Mac­
kenzie (1954) that above a critical level of serum tocopherol, there 
is complete protection against the hemolytic response. 
On the other hand, even the group receiving a zero vitamin E 
supplementation to the SO diet showed no perceptible increase in per­
cent hemolysis. Although we expected this group to be vitamin E 
deficient, there is evidence they were not. In the semi-purified 
diet provided to the animals, only the SO could have been a source 
of vitamin E. The a-tocopherol content of SO is generally 0.34 mg/g 
oil (McLaughlin and Weihrauch 1979), although determination of the 
a-tocopherol content of our particular batch of SO revealed only half 
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as much a-tocopherol (0.112 mg/g oil). Discussions with the quality 
control manager of the SO manufacturer revealed the company used TBHQ 
as added antioxidant; tocopherol contents were believed low due to 
processing. Rats in these experiments, therefore, were receiving 
0.31 mg o^tocopherol/day from SO alone or 22 mg/kg diet. Although 
the diet itself was not altogether void of cv-tocopherol, the level 
present was presumptively deficient. Failing to observe symptoms of 
vitamin E deficiency, one must conclude that the minimal amount of 
Qf-tocopherol in the SO used was adequate to delay appearance of deficiency 
symptoms. 
The purpose in the present investigation was not to produce a 
vitamin E deficiency, in any case. The 0-T group was included as one 
part of a wide spectrum of levels of a-tocopheryl acetate supplementa­
tion. Although there was no intention to produce vitamin E deficiency, 
the results suggest two measures that would be useful in such a 
purpose: (1) use of a more completely stripped SO, treated with non-
biological antioxidants, and (2) continuation of the 0-T regimen 
exceeding 45 days. 
The method of hemolysis analysis herein employed is based on 
spontaneous hemolysis in saline-phosphate buffer rather than the older 
dialuric acid method. The former method is more sensitive than the 
latter (Draper and Csallany 1969). Aftergood and Alfin-Slater (1978), 
using the Draper and Csallany method, reported RBC hemolysis of rats 
fed 1.0 mg/day or 5.0 mg/day a-tocopherol for 12 weeks was 4,5 + 2.3% 
and 3.8 + 1.4%, respectively. Comparable values from the present 
study are 5.9 + 1.1% and 7.2 + 1.1%, indicating agreement with Aftergood 
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and Alfin-Slater that increasing o-tocopherol was of no significant 
benefit in lowering erythrocyte hemolysis. 
Although statistically not significant, the lowest RBC hemolysis 
value occurred in the EFAD group. To our knowledge hemolysis per se 
has not previously been measured in EFA deficiency. A group of in­
vestigators reported that osmotic resistance of erythrocyte membranes, 
measured by dropping whole blood into NaCl solutions of varying concentra­
tions, was no different in EFA deficiency or adequacy (Bohles ejt al. 
1979). Another study showed that rabbit RBCs were resistant to peroxida-
tive hemolysis until arachidonate was added to the medium (Brin et 1974). 
The rabbits were not EFA deficient, although they were vitamin E de­
ficient. One cannot conclude with assurance that in a vitamin E suf­
ficient state, reduced PUFA would make the RBC membranes more stable, 
although the results indicate that is possible. 
A reduced hemolytic response may be explained in at least two 
ways. (1) The EFAD group was 6 weeks younger than the other treatment 
groups. Thus, any difference observed between EFAD and the other 
groups may be an age rather than diet difference. Caution should be 
employed in making any direct comparisons. The age-related studies 
reported earlier show greater hemolysis in the young, but that is thought due 
to reduced cï-tocopherol stores in the young (Gordon and Nitowsky 1956). 
Whether age, independent of of-tocopherol content of the body, af­
fects hemolysis is unclear. (2) Hemolysis is a result of fragile red 
blood cell membranes, and membrane integrity depends in part upon 
structural lipids. Current theory holds that membranes, rich in 
PUFA, are structurally sound as long as the PUFA remains unoxidized. 
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If peroxidation occurs, the membrane is disrupted and hemolysis potential 
is increased. Alpha-tocopherol, as an antioxidant, can prevent the 
loss of membrane integrity. In EFAD it is possible (1) that membranes 
are depleted in PUFA, (2) that the ratio of E:PUFA is increased, (3) that 
the remaining scarce PUFA are more vigilantly protected from peroxida-
tive damage. 
Effect of Diet on Lung Weight 
Size of the lung was affected by a-tocopherol supplementation. 
In Experiment II animals in the experimental group receiving 10 mg dl-
of-tocopheryl acetate/day had significantly smaller lungs than animals 
in all other groups (Table 14). This is an intriguing and puzzling 
observation. Experimental group 10-T was a maverick on several variables 
measured. This group had the highest hemolysis value, lowest food 
efficiency, and lowest weight gain of all experimental groups refed 
with SO and graded levels of a-tocopheryl acetate. Group 10-T also 
had lower pulmonary C18;2iu6 and higher C16:0 than the other groups 
at the conclusion of the experiment. Initial body weight and weight 
at end of EFA depletion were not different from the other groups (Tables 
9 and 14). Serum fatty acid profile of group 10-T was not different 
from the other groups at the end of depletion (Table 10). Thus, as far 
as can be known, no selection bias accounts for the data obtained 
for group 10-T. The differences were not large enough to be 
statistically significant by ANOVA or by t-tests but that this group 
deviated consistently from all other groups on so many variables 
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suggests something unique about the group. That the lungs were 
significantly smaller in group 10-T than in the other treatment groups 
may partially explain the poor showing on indices of health. A 
limited pulmonary capacity may restrict growth and general well-being. 
When lung size was considered relative to body weight (Table 14), 
groups 10-T and 1-T differed significantly. 
If the treatment group receiving 20 mg o-tocopheryl acetate/day 
had responded in a similar manner to the group receiving 10 mg/day, 
then one may have concluded the effects were due to excessive a-
tocopherol Ingestion. That is not the case. A basic assumption in 
nutrition science is that every nutrient has a continuous effect upon 
the organism. As graphically portrayed in Figure 10, both deficiency 
and excess of a nutrient are accompanied by deleterious effects, while 
a middle, moderate range is associated with optimum functioning. If, 
for example, the nutrient in question were EFA and the response were 
growth, we would observe at suboptimal intakes a depressed growth, at 
optimal intakes maximum growth, and at excessive intakes depressed 
growth. Thus, in the case of a-tocopherol we would also expect to ob­
serve a continuous effect of increasing dose, a uniformly progressive 
decline or increase in lung weight, or weight gain, for example. What 
we report, however, is a break in the continuous curve. While it is 
conceivable that increasing a-tocopheryl acetate intake from 1 to 5 
to 10 rag/day could lead to deleterious effects at the highest dose, 
what is inconceivable, given our current assumptions, is that a further 
increase to 20 mg/day should reverse the trend.' The continuous ef­
fect model is a simplified statement of nutrient effect ignoring the 
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10. Generalized continuous response curve of a nutrient 
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reality that nutrients act in concert. The observations of group 10-T 
may be strictly random but may on the ether hand result from an un­
defined nutrient interaction. 
Pulmonary a-Tocopherol 
Results show that increasing levels of a-tocopheryl acetate in the 
diet were associated with slightly increased concentrations of a-
tocopherol in lung tissue. The increase in daily supplementation from 
1 mg to 20 mg was accompanied by a rise in lung as tocopherol from 46.7 
Pg/g to 63.2 pg/g lung. Although the increased pulmonary concentration 
was statistically significant, it was only a modest response to large 
dietary increases. Linear regression showed that a straight line was 
a poor fit to the data, primarily because of wide variation within 
groups. In the third experiment dietary a-tocopheryl acetate was 
raised to 50 mg/day. Pulmonary content of o;-tocopherol under this 
treatment was 63.3 pg/g lung, no higher than when intake was 20 mg/day 
in Experiment II. Furthermore, the third experiment failed to show 
any statistical difference among treatment groups in pulmonary a-
tocopherol content. 
The effect of dietary o*-tocopheryl acetate on pulmonary a-
tocopherol accumulation is minor at best and straitly restricted. 
Although increased intake of a-tocopherol results in apparent ac­
cumulation in plasma and liver, the lung is less responsive (Aftergood 
and Alfin-Slater 1978). This finding is consistent with data related 
to lung composition. The total fat content of pulmonary tissue is 
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relatively small. But more important, 50% of pulmonary lipid is in the 
phospholipid fraction, and this fraction is of a relatively fixed 
composition, somewhat resistant to dietary changes (Higgins 1979). A 
small nonphospholipid pool in lung suggests a limited ability to ac­
cumulate and store fat-soluble vitamins. 
Witting (1975) reported ^-tocopherol was present in tissues largely 
in the subcellular membranes; therefore, incorporation and storage of 
a-tocopherol in tissues would be severely limited. Bieri et al. (1978) 
fed rats graded levels of crtocopheryl acetate from 30 to 50 mg/kg diet 
for 8 to 10 weeks and found no change in the cy-tocopherol content of 
lung. 
Comparisons of pulmonary tocopherol data from the present investiga­
tion with earlier published results show close agreement with Aftergood 
and Alfin-Slater (1978) under similar conditions. That Evarts and 
Bieri's (1974) values of pulmonary ^tocopherol are much lower than After-
good and Alfin-Slater ' s and the results herein may be due to two factors. 
(1) Evarts and Bieri did not supplement the corn oil diet with vitamin 
E as did the others. (2) Evarts and Bieri reported a value based on 
only two rats. Our results with over 100 rats indicated wide varia­
tion in the rat population and high error in a small sample. 
It is evident from the SEM that a relatively high error persists 
in Of-tocopherol measures (Tables 14 and 20). Such error is due to at 
least two factors: (1) a genuinely wide biological variability in the 
population and (2) error in the method. That the latter is partly to 
blame became clear as refinement of the method occurred during use. 
Only in the hands of a skilled analyst can the potential for variation 
Table 23. Comparisons of literature values for pulmonary a<-tocopherol in rats 
Evarts and 
Bieri 
(1974) 
Âftergood and 
Alfin-Slater 
(1978) 
Work 
herein 
Pulmonary a-tocopherol 
(Hg/g lung) 21.6 56.0 + 5.6* 59.0 ± 3.8* 
Diet 20% corn oil 15% corn oil 
5 mg Of-tocopherol/day 
20% SO 
5 mg tocopherol/day 
Length of feeding 8-12 weeks 6 weeks 6 weeks 
^Mean + S EM. 
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be reduced. Alpha-tocopherol, unstable, readily oxidized by air, light, 
heat, was sensitive to even slight differences in sample handling and 
preparation, as indicated by duplicate disagreement. 
In general, levels of of-tocopherol in lung reported here are similar 
to those reported by others, and little pulmonary retention of exces­
sive a-tocopherol intakes occurred. 
When EFAD animals are compared to the other treatment groups in 
Experiments II and III, the EFAD animals had a relatively high 
pulmonary «-tocopherol content despite an of-tocopheryl acetate intake 
of only 1.0 mg/day and despite an age difference of six weeks com­
pared to other treatment groups. As has previously been mentioned, 
a-tocopherol levels are generally low in very young animals. At the 
ages in these experiments, 86 days old (EFAD group) vs 111 days old 
(SO and of-tocopheryl acetate treated groups), thé age effect on tissue 
CÏ-tocopherol content is not known. In the absence of a proper control 
group for comparison with the EFAD group one cannot make clear evalua­
tion of the EFAD results. Nevertheless, it appears that EFAD animals 
have increased pulmonary cy-tocopherol (Tables 14 and 20). Although 
plasma «-tocopherol was not measured, the high pulmonary «-tocopherol 
values are consistent with the trend towards reduced hemolysis seen 
in EFAD animals. In a state of EFA deficiency (1) the organism might 
compensate for EFA scarcity by accumulating protective molecules, or 
(2) reduced substrate for lipid oxidation might diminish use of the 
vitamin and enhance accumulation. 
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Serum Fatty Acid Pattern 
Rats entered the experimental phase having been uniformly depleted 
of EFA. Mean serum T/T ratios in Experiments II and III ranged from 0.47 
to 0.83; all within the biochemical definition of EFA deficiency. Serum levels 
of C18: 2w6 and C20:4(i)6 were reduced to half of control levels (Table 8) . At this 
juncture all rats to be continued in the experiment were placed on a 
20% by weight SO diet, with 31% of calories supplied by C18:2iu6. The 
excess C18;2u)6 intake was accompanied by 0, 1, 5, 10, or 20 mg/day 
dl-Of-tocophery 1 acetate in Experiment II or by 0, 1, or 50 mg/day dl-
of-tocophery 1 acetate in Experiment III. The levels of the a-tocopheryl 
acetate in supplements in Experiment II had no statistically significant 
effect on any of the fatty acids measured. Apparently vitamin E did not 
influence the conversion of dietary linoleate to arachidonate. Data 
from Experiment III partially confirm these results. Statistical 
analysis shows dietary «-tocopherol level did not affect serum fatty 
acid profile (Table 17). Closer examination suggests that, despite 
lack of statistical significance, the 50 mg/day dose of vitamin E 
tended to elevate serum C18:2(u6 and lower serum C20:4u)6. Linoleate in 
groups 0-T and 50-T was 22.86 + 2.61% and 30.96 + 4.19%. Arachidonate 
in groups 1-T and 50-T was 25.02 + 1.76% and 18.75 + 1.76%, respectively 
(Table 17). 
Expression of the relationships among fatty acids by means of 
ratios enables one to see more clearly the effects of the a-tocopherol 
supplementation (Table 19). Essential FA deficiency significantly 
elevated the C18:l/C18;0 ratio, the C20:4w6/C18:2w6 ratio and the 
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C20:3(1)9/020;4(1)6 + C18:2(o6 (T/T + D) ratio. These ratios reflect the 
A9, Û6 and As desaturase activities (Rivers and Hassam 1975). Eleva­
tion of all three ratios in the EFAD groups suggests enhanced desaturase 
activities. Removal of the EFAD group from comparison and consideration 
of 0-T, 1-T, and 50-T suggests that the group of rats receiving the 
high vitamin E dose had a statistically significant reduction in 020:4(1)6/ 
018:2(1)6 ratio, although the other two ratios were unaffected. A re­
duced 020:4(1)6/018:2(1)6 ratio suggests that excessive vitamin E intake 
altered the balance among these two fatty acids. Calculation of 020:4(1)6/ 
018:2(1)6 ratios from serum data of Experiment II yielded values of 0.85, 
0.94, 1.02, 0.85, and 0.94 for the 0, 1, 5, 10, and 20 mg/day supple­
mented groups. Although 20 mg/day vitamin E had no significant effect 
on serum FA profile, 50 mg/day did alter the relative amounts of 018:2(1)6 
and 020:4u)6 (Table 19). The mean 020:4(1)6/018;2u)6 ratios in Experiment 
III were 1.21 for the 1-T group and 0.73 for the 50-T group (p < .05). 
As 020:4(1)6 is mostly of endogenous origin, this finding suggests exces­
sive levels of vitamin E may hinder the conversion of 018:2(1)6 to 020:4u)6, 
perhaps through influence on A6 desaturase. Another possible explanation 
is that excess a-tocopheryl acetate protected one fatty acid from oxida­
tive destruction more effectively than the other. 
The observation that 20 mg/day vitamin E supplementation did not 
affect serum fatty acid profiles, while a 50 mg/day dose did produce 
a change, is consonant with the findings on body weight. A dose of 20 mg/ 
day did not depress growth (Table 9), while 50 mg/day began to depress 
growth at the end of the experimental period (Figure 8). One concludes 
that vitamin E intakes up to 40 times the requirement may not be 
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deleterious to the rat, but Intakes at 100 times the requirement may 
be harmful. This conclusion is based, of course, on only two measures 
which may be unrelated and may be unimportant to overall health and 
well-being. 
Pulmonary Fatty Acid Pattern 
Essential FA deficiency produced a fatty acid pattern in lung 
similar to, but less pronounced than, the pattern in serum. In Table 24 
serum and pulmonary fatty acids in the EFAD group of Experiment II are 
compared. Lung has a much higher relative amount of C16;0 than serum, 
which is explicable by the contribution of pulmonary surfactant. Lung 
has much lower relative concentration of C16:l, C18:0, C18:2cu6, and 
C20;3u)9 and a slightly lower proportion of C20:4cu6 than serum. Lung 
has a somewhat higher proportion of C18:l than serum. The T/T ratio 
of EFAD lung lipids does not approach the value apparent in serum 
lipids, suggesting lung tissue is resistant to EFA depletion. 
The pulmonary level of C20:4(Ju6 was similar to the serum level, 
but C18:2œ6 was nearly fivefold lower in lung than in serum. Clearly, 
EFA depletion has made inroads, although the simple T/T ratio masks the 
effect. In Experiment II the serum total lipid T/T ratio was 0.47, 
while the pulmonary total lipid T/T ratio was 0.14. In Experiment 
III the pulmonary total lipid T/T ratio was 0.20. Pulmonary C18;2tu6 
was again much lower than serum C18:2(u6. In general, replication of 
pulmonary fatty acid patterns was good between Experiment II and 
Experiment III EFA depletions. 
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Table 24. Serum and pulmonary fatty acid profiles after 45 days of 
EFA depletion. Experiment II 
Fatty 
acid Serum Lung 
16:0 23.16 ± 1.03* 42.90 + 0.98 
16:1 3.38 ± 0.47 1.33 ± 0.55 
18:0 22.53 ± 0.97 12.29 ± 0.53 
18:1 21.56 ± 1.00 29.17 ± 0.32 
18:2u)6 10.46 ± 1.05 2.40 ± 1.18 
18:3m3 Trace Trace 
20:3cu9 6.05 + 0.66 1.41 ± 0.19 
20:4uu6 12.84 + 1.28 10.48 ± 0.10 
T/T 0.47 0.14 
^MEAN + SEM. 
A more complete description of tissue fatty acid patterns than 
T/T ratio alone gives may be obtained using three additional fatty 
acid ratios (Table 19). Essential FA deficiency elevated the C18:l /C18;0 
ratio compared to essential fatty acid sufficiency. This ratio identi­
fies an enhanced desaturase activity which, in a deficiency of PUFA, 
reflects an attempt to produce unsaturated fatty acids from the 
materials at hand. The C20:3M9/C20:4W6 + C18;2oj6 (triene/tetraene + 
diene, T/T + D) ratio is also elevated in lung in EFA deficiency. This 
ratio provides a more comprehensive statement about EFA status than the 
T/T ratio for the former also accounts for tissue depletion or retention 
of C18:2AJ6. Serum has a fourfold higher T/T ratio than lung in EFA 
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deficiency, \^ile lung is more depleted of C18:2cu6 than is serum. 
Thus, when these two observations are combined in one ratio, the values 
are 0.40 and 0.17 for serum and lung, respectively. The EFA status of 
the two tissues is closer than the T/T had indicated (Table 25). Al­
though the lung is still conservative of PUFA in the face of EFA 
deficiency, the effects of the lack of dietary PUFA are clearly evi­
dent . 
Table 25. Comparison of indices of EFA deficiency in serum and pul­
monary total lipids. Experiment III 
Serum Lung Serum/lung 
T/T 0.66 0.20 3.3 
T/T + D 0.40 0.17 2.4 
In Experiment II graded levels of dietary crtocopheryl acetate 
had no significant effect on fatty acid pattern in pulmonary total 
lipid. One has to conclude that dietary a-tocopheryl acetate intakes 
up to 20 mg/day are of no influence on any of the fatty acids measured. 
Other investigators have reported similar results (Miller and White 1975, 
Schoene and Lehmann 1978) , Donovan and Menzel (1979) and Donovan et al. (1977) 
fed Qf-tocopheryl acetate at 105 mg/kg diet and found no effect on mouse 
pulmonary fatty acid composition. We provided a-tocopheryl acetate at 
1420 mg/kg diet and still found no change in rat pulmonary fatty acid 
profile due to excess tocopherol. Even when o^-tocopheryl acetate sup­
plementation rose to 50 mg/day or 3750 mg/kg diet, no statistically 
significant differences appeared in C18:2UJ6 or C20:4IU6 levels in lung 
114 
(Table 18). The C20:4(u6/C18; 2cu6 ratio showed no difference in rela­
tive amounts of U)6 fatty acids. The animals receiving 50 mg vitamin E 
daily had relatively no less C20:4u6 and relatively no more C18:2m6 
in pulmonary total lipids than animals receiving 1 mg vitamin E daily 
(Table 19). This similarity in relative amounts of C18;2u)6 and C20:4(u6 
in lung total lipids despite vitamin E supplement contrasts with the 
result in serum. While in serum dietary vitamin E seemed to alter the 
balance of C18:2a6 and C20:4ou6, the evidence does not support a similar 
conclusion for lung. Possibly the tissue difference arises from cr 
tocopherol content of the tissues in question. Although serum a-
tocopherol was not measured, there is evidence that serum vitamin E 
rises in response to diet (Lehmann et 1977a, Aftergood and Alfin-
Slater 1978). Measures of pulmonary (%-tocopherol suggest that lung 
has only a limited ability to accumulate vitamin E. The lung, there­
fore, may be shielded from effects of excess vitamin E intake. 
The data do not support the conclusion that excess of dietary 
vitamin E has an influence on pulmonary fatty acid pattern. Many 
investigators have shown that a deficiency of vitamin E is associated 
with a decline in C18:2UJ6 and a rise in C20:4UU6 (Witting and Horwitt 
1967, Lee and Barnes 1969). As yet, an excess of vitamin E has not 
been associated with any alteration in fatty acid profile. Other 
investigators have used moderate vitamin E supplementation and for 
relatively short feeding periods. Donovan and Menzel (1979) fed 
at most 105 mg dl-a-tocopheryl acetate/kg diet for six weeks, while 
we fed 3750 mg dl-o-tocopheryl acetate/kg diet for six weeks. A trend 
to growth depression appeared only in the final two weeks of Experiment 
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III. Failure of others to observe effects of a-tocopheryl acetate dose 
may be due to (1) too short an experimental period, (2) too subtle and 
too moderate a difference in vitamin E treatment, (3) insulation of 
lung or other tissue from excess vitamin E intakes, or (4) absence of a 
genuine effect of vitamin E on the variables considered. The results 
do not provide the final answer but do suggest possibilities that 
ought to be more fully studied before a firm conclusion can be drawn. 
Prostaglandin Synthesis 
A reduction in PG synthesis has been observed in EFA deficiency. 
Our results also suggest that whole blood PG synthetic rate was de­
pressed in EFA deficiency. Conçarisons of group EFAD with the other 
three experimental groups are made with the awareness of an age dif­
ference. The EFAD group was six weeks younger than the 0-T, 1-T, and 
50-T groups. Glenn et al. (1972) reported that PG synthesis increased 
with age. Thus, the data may reflect an effect of age rather than diet. 
Nevertheless, support for reduced PG synthesis in EFA deficiency is 
found in work by Vincent et al. (1974), Parnham et (1979), Weston 
and Johnston (1978), and others. An apparent reduction in synthesis 
of PGEg and PCFg^, in serum was not statistically significant but 
reduced synthesis of PGE^ in serum was significant (Table 21). 
Fine et al. (1980) found that altering dietary P/S ratio from 0.4 to 
5.5 had no effect on PGFg^ and PGE^ synthesis in lO-minute Incubated 
whole blood. A general trend of increased PGE^ synthesis with in­
creasing P/S ratio was seen. Our results support these findings. 
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The significant reduction in serum PGE^ and the less pronounced 
depression of serum PGE^ and by EFA deficiency are a logical 
consequence of availability of fatty acid precursors. Comparing the 
EFAD group with the three SO groups reveals C18:2w6/C20:4w6 ratios of 
0.71 for the former and 1.25 for the latter. What these ratios show 
is that the amount of C18;2cu6 relative to C20:4tu6 is reduced in 
serum in EFA deficiency. Although relative concentrations of both 
C18;2cu6 and C20:4w6 decline in EFA deficiency, C18:2u)6 drops lower than 
C20:4u)6, As linoleate is precursor to PGs of the one series and 
arachidonate is precursor to PGs of the two series, the pattern of PG 
depression in Table 21 is precisely as expected. Essential FA deficiency 
depresses synthesis of PGs of the one series more than it depresses 
synthesis of PGs of the two series. 
Although EFA depleted, the animals exhibited a smaller reduction 
in C18:2u)6 and C20:Au)6 in lung than in serum. Lung was mildly protected 
from the effects of EFA deficiency, depleting slowly, as evident in both 
the T/T ratio and the T/T + D ratio. A known inhibitor of PG synthesis, 
C20:3ai9 was lower in lung than in serum (Tables 17 and 18). Thus, less 
depression of PG synthesis occurred in lung than in serum. In pulmonary 
total lipids the level of C20;4(u6 was no lower in EFAD than in the other 
groups. No reduction of synthesis of PGs of the two series would be 
expected. While the level of C18:2w6 was clearly lowered in lung in 
EFAD, the measured level of PGE^ was low enough in all groups to obscure 
any differences. Prostaglandin E^ may be low in lung due to rapid 
metabolism. 
That pulmonary prostacyclin should be elevated in EFA deficiency 
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is an unexpected finding. Very few measures of PGIg have been re­
ported. Hornstra and Haddeman (1978) reported PGIg was decreased in 
aortic endothelium of EFA deficient animals. Hornstra and Hemker (1979) 
confirmed the reduction of prostacyclin synthesis in EFA deficiency. 
Although the present results appear to contradict these findings, 
attention to details of the diets used suggests complex factors 
entering into the comparisons. Hornstra and Haddeman (1978) compared 
EFA deficiency induced by a fat-free diet with a control diet con­
taining fat. Thus, PGIg synthesis may have been reduced by level rather 
than composition of dietary fat. Hornstra and Hemker (1979) controlled 
level of fat by comparing rats fed 5% of calories as sunflower seed 
oil or hydrogenated coconut oil. Although level of fat was consistent, 
5% of calories is a low-fat diet. Dupont et (1980) showed that the 
change in rate of PG synthesis in response to change in C18;2to6 
intake was not a simple curve of positive slope. Increasing intake 
of linoleate from 0 to 2 percent of calories was associated with 
increased PG synthesis. Increasing linoleate intake from 2 to 7% 
of calories was associated with a drop in rate of PG synthesis. In­
creases of linoleate intake over 7% of calories were again associated 
with increased rate of PG synthesis. Hornstra and Hemker's sunflower 
seed oil diet was 3% of calories as linoleate. Thus, they were feeding 
in the area of the PG synthesis curve that Dupont £t al, (1980) called 
"abnormally regulated." Evaluation of the decreased PGI^ synthesis 
in EFA deficiency is difficult. It is impossible to conclude from the 
data presented whether the elevated PGIg in our experiment was the 
result of an artifact, an effect of age or diet, or a combination of 
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several factors. 
Dietary cy-tocopheryl acetate was of no effect on PG synthesis in 
arterial blood or lung homogenate measured after ten minutes of incuba­
tion. Lands et al. (1973) reported in vitro inhibition of PG synthesis 
by o-tocopherol, but Zenzer and Davis (1978) were unable to find inhibi­
tion when using concentrations in the incubation medium exceeding those 
used by Lands et al. Either the inhibition occurred only at low 
concentration of ortocopherol or there was no genuine inhibition. In 
vivo work has not clarified the issue. Likoff et (1978) found that 
PG synthesis in chick spleen was inhibited by feeding a high-vitamin E 
diet. Our results suggest inhibition of PG synthesis in lung or serum 
cannot be attributed to excess dietary of-tocopherol intake. 
Many effects of excess vitamin E intake have suggested some derange­
ment of PG metabolism — platelet aggregation (Nafstad 1974) , altered im­
mune response (Corwin and Shloss 1979), protection from ozone toxicity 
(Menzel et 1978) — but very few measures of PGs in animals or man 
ingesting excess vitamin E have been reported. More information must 
be gathered to arrive at a definitive answer. Specific tissues, 
tissue fractions, species, ages, tocopherol isomers, doses, and 
individual prostaglandins must be considered. 
In theory crtocopherol could act to inhibit PG synthesis by 
altering the relative concentrations of fatty acid precursors. Of 
this we found no evidence in lung. Alpha-tocopherol affected neither 
fatty acid substrate nor PG product. In serum, while the amount of 
C20:4w6 was reduced relative to C18;2u)6 on the 50 mg/day vitamin E 
supplement, there was no concomitant reduction in PGE2 and PGF2a 
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relative to PGE^. As with growth depression, perhaps a longer experi­
mental period would have allowed differences to appear. On the other 
hand, the experimental period may have been too long already, and any 
differences were moderated by adaptations over time. 
The PGE^/PGEg + ratio permits a single, comprehensive 
comparison of shifting balances among PGs of the one and two series. 
If a-tocopherol were to alter the balance of C18:2w6 and 020:4(1)6, then 
one might expect a similar shift in relative amounts of one and two 
series PGs. Alpha-tocopherol was of no significant effect on PG ratio 
in lung or serum. Dietary ffl-tocopherol appears to have no effect on PG 
synthesis mediated through effect on FA precursors. 
Comparison of reported values for PG synthesis is difficult. Method 
of analysis, diet, tissue, handling, reagent purity all influence 
results. Samuelsson et al. (1978) discussed the many sources of error 
in measurement of PGs. Prostaglandins occur in minute quantity such 
that slight variations in laboratory protocol may have large consequences. 
Prostaglandins are produced in response to mechanical stimulation. 
Thus, collection of the sample itself introduces possible error. In 
our laboratory different batches of antiserum and buffer have been 
shown to affect the assay results. Incubation of sample allows PG 
synthesis to proceed, and maximum levels are reached after different 
periods for different tissues. Incubation permits observation of PG 
synthetic rate and allows a measure of control over the error intro­
duced in sample collection. Nonincubation of sample permits analysis 
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of endogenous PG levels. Work is currently underway to examine and 
compare the levels of PCs measured before and after incubation in a 
variety of tissues. 
A comparison of measured values of PGs using the same RIA 
procedure appears in Table 26. In arterial serum our PGE^ values are 
lower than those of other investigators. This is easily explained 
by the differences in incubation procedure. Hwang et al. (1975) did 
not incubate, which should reduce PG values. However, they did not add 
aspirin to the sample to inhibit further PG synthesis. Prostaglandin 
levels in samples rise over time in the absence of a nonsteroidal anti­
inflammatory drug. Hwang ai\d Kinsella (1978) incubated 60 minutes which 
permitted more PGE^ synthesis than our 10-minute incubation. Our 
serum PGEg value is lower than that of Hwang and Kinsella, again due 
to variation in length of incubation period. Our serum and lung PGEg 
levels are very similar to those of Mathias and Dupont's (1979) which 
were obtained under identical incubation conditions. Our serum and 
lung PGFg^^ values are much higher than any other reported. This is 
probably an effect of diet. Mathias and Dupont fed only 20% of calories 
as fat with a P.S ratio of 5.5. We fed 38% of calories as fat with a 
P.S ratio of 8.6. 
Diets high in PUFA have sometimes been shown to have harmful ef­
fects. The same diets have been associated with elevated PG synthesis. 
In addition, vitamin E requirements rise with increasing dietary 
PUFA, ^nd vitamin E has inhibited PG synthesis in vitro. The hypothesis 
9 personal communication. 
Table 26. Comparison of PG levels in rat serum and lung, determined 
by RIA 
Tissue Conditions Diet 
Hwang et al. 1975 Arterial 
serum 
Hwang & Kinsella 
1978 
Arterial 
serum 
No incubation 
No aspirin 
60-min incub. 
20% corn oil 
ll%cis 18:2(u6 
11% HCO 
Mathias & Dupont 
1979 
Work 
herein 
Lung 
Serum 
Lung 
Arterial 
serum 
10-min incub. 
10-min incub. 
10-min incub. 
10-min incub. 
20% calories as fat 
P/S 5.5 
20% calories as fat 
P/S 5.5 
20% SO by weight 
20% SO by weight 
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PGE, PCE, PGF la 
1.57 + 0.23 
ng/ml 
5.69 ± 0.59 
ng/ml 
1.10 + 0.24 
ng/ml 
24.89 ± 4.35 
ng/ml 
2,19 ± 0.85 
ng/ml 
2.77 ± 0.42 
ng/ml 
0.91 ± 0.14 0.50 ± 0.08 
ng/mg ng/mg 
5.4 ± 1.5 3.8 + 0.6 
ng/109 platelets ng/lO® platelets 
0.08 + 0.01 0.28 + 0.02 7.61 + 0.94 
ng/mg ng/mg ng/mg 
0.69 + 0.15 5.50 + 0.99 14.23 + 2.61 
ng/ml ng/ml ng/ml 
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tested by the present investigation was that vitamin E, taken in adequate 
amounts, could counteract the effects of high PUFA diets by altering 
PG precursor fatty acids and PG synthesis. 
On the basis of the results reported herein, one cannot conclude 
that increasing intakes of of-tocopherol would ameliorate the deleterious 
effects due to high PUFA diets through modification of PG synthesis. 
No benefits from high vitamin E intake and some potential disadvantages 
were observed. Failure to support the hypothesis does not prove 
it to be false. The findings may be in error. The variables selected 
for observation and the methods used may be insensitive. Although the 
data fail to so indicate, real differences may exist. 
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SUMMARY 
The purpose of this work was to test the interrelationship of 
dietary vitamin E, dietary linoleic acid, and prostaglandin synthesis. 
Level of dietary PUFA has been associated with PG synthesis. In EFA 
deficiency PG synthesis was depressed, and on diets with P/S ratios 
over 5.5 PG synthesis was elevated. Vitamin E seemed to inhibit PG 
synthesis in vitro, and vitamin E deficiency in animals was associated 
with both depressed (Chan et 1979) and elevated (Hope et 1975) 
PG synthesis. As the initial step in PG synthesis is formation of a 
peroxide and as vitamin E is a recognized antioxidant, it has seemed 
reasonable to expect an influence of tocopherol on PG synthesis. Further­
more, desaturation of linoleate to produce arachidonate (both PG pre­
cursors) is an oxidative reaction which may be inhibited by vitamin E. 
Enhanced platelet aggregation — a function mediated at least in part 
by prostaglandins — occurs with diets either high in PUFA or deficient 
in vitamin E. Other effects of high PUFA diets have suggested PG in­
volvement. Requirement for vitamin E is related to intake of PUFA. 
Thus, the hypothesis for this work was; an increase in dietary a-
tocopherol will modify the pulmonary and serum concentrations of pre­
cursor fatty acids and will alter PG synthesis. Alpha-tocopherol will 
prevent conversion of linoleate to arachidonate and thereby alter the 
balance of PGs of the one and two series. 
In order to observe interrelationships of dietary crtocopherol and 
dietary linoleic acid, a pre-experimental EFA depletion period was used. 
In Experiment I male rats were fed a 20% HCO, 26% casein diet in order 
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to deplete tissue reserves of EFA. Periodic blood samples were taken 
for determination of T/T ratios, and growth was observed in order to 
monitor progress of EFA deficiency with time. In Experiments II and 
III the initial EFA depletion period (45 days) was followed by 45 
days of refeeding with 20% safflower oil and graded levels of dl-cr 
tocopheryl acetate. In Experiment II dl-crtocopheryl acetate was given 
in dietary supplements of 0, 1, 5, 10, or 20 mg/day. In Experiment III 
vitaminE was fed at 0, 1, or 50mg/day. AnEFAD group, killed at the end of the 
depletion period, was also included in Experiments II and III. Dependent 
variables observed were weight gain, food intake, hemolysis, pulmonary a-
tocopherol, pulmonary and serum fatty acid profiles, pulmonary PGE^, PGEg, 
PGFg^, PGI^, and serum PGE^, PGE^, and PGF^^. From these measures fatty acid 
ratios were developed to compare relative amounts of selected fatty acids. 
Essential FA depletion had marked effect on fatty acid profiles 
of serum and lung. Linoleate and arachidonate decreased while 
eicosatrienoate and oleate rose. The effect was more pronounced in 
serum than lung. Pulmonary tissue was resistant to, but not untouched 
by, the deficiency. While T/T ratios of serum were greater than 0.4 
within 45 days of beginning EFA depletion, lung T/T ratios were less 
than 0.20. However, lung showed greater reduction in linoleate than 
did serum. Thus, a C20:3W9/C20:4W6 + C18:2uj6 ratio was proposed that 
more accurately reflected the depletion of UJ6 fatty acids. Use of the 
T/T + D ratio showed the effects of EFA deficiency on lung and serum 
to be more similar than the T/T ratio had suggested. 
The effect of EFA depletion on PG synthesis was tissue and pro­
stanoid specific, and no generalization was possible. In blood PGE^ 
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synthesis was depressed. In lung PGI^ synthesis was elevated. Serum 
PGEg, PGFg^, pulmonary PGE^, PGE^, and PGF^^ syntheses were not 
significantly altered. An explanation for the .general absence of 
depression of PG synthesis is obscure, particularly in view of the clearly 
reduced levels of PG precursor fatty acids and the elevated level of 
inhibitory eicosatrienoic acid. 
In general it was difficult to see any effect of progressive level 
of dietary vitamin E on any of the dependent variables. Growth was 
generally unchanged except for the appearance of a slight growth depres­
sion after nearly 45 days of feeding 50 mg dl-crtocopheryl acetate/day. 
A very limited accumulation of o^tocopherol in lung was observed. No 
decrease in percent RBC hemolysis was associated with excessive vitamin 
E intakes. No alteration in FA profile of serum or lung was obvious 
with vitamin E intakes up to 20 mg daily. However, in the 50-T 
group the serum C20:4u)6/C18:2u)6 ratio was significantly lower than in 
the 1-T group. Such an effect was not observed in lung. This 
tissue difference was consonant with the accumulation of (^-tocopherol 
in the tissue. Lung had slight deposition of «-tocopherol in response 
to excessive dietary intakes while serum «-tocopherol is believed to 
reflect dietary vitamin E. 
Increased linoleate relative to arachidonate in serum of the 
• . 
50-T group supported the hypothesis that vitamin E would retard conver­
sion of linoleate to arachidonate. The effect was not extended to PG 
I 
synthesis, however. No inhibition of synthesis of PGs of the two 
series relative to the one series was evident in blood or lung. 
In general the data do not support the hypothesis. Alpha-
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tocopherol was seen to have little effect on fatty acid pattern of 
serum and no effect on fatty acid profile of lung. In neither tissue 
was PG synthesis altered by level of intake of vitamin E. The evidence 
does not support a beneficial role for vitamin E in high-PUFA diets. 
On the other hand, the hypothesis is not proven false. Only 
selected variables were observed. An effect of dietary ortocopherol 
might be evident in other tissues or other functional measures. More­
over, the procedures used in this work may be insensitive to genuine 
differences. Further efforts on the relationship of vitamin E, fatty 
acids, and prostaglandins are warranted. Although a zero-supplemented 
group was included in this research, no evidence of a genuine vitamin 
E deficiency appeared. In order to determine whether or not vitamin E 
actually has a part in regulation of fatty acid-prostaglandin metabolism, 
it is essential to produce a frank vitamin E deficiency and observe the 
functional consequences. The length of feeding may have masked dif­
ferences. Thus, future work might feed animals a similar high-PUFA diet 
and graded levels of vitamin E for three different experimental periods — 
21 days, 45 days, and 90 days. The elevated prostacyclin aynthesis in 
EFA deficiency requires confirmation and explanation. The differing 
responses of prostanoids to the EFA deficient diet suggests a need to 
avoid generalizations and to observe each prostaglandin, thromboxane, 
and endoperoxide metabolite for its response to dietary manipulation. 
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Table 27. Ant1sera used for PG-RIA. Experiment III 
Antisera Batch Date 
Working 
dilution % binding 
Anti-PGE^ R 1005 10/17/73 1:3000 25% 
Anti-PGFga 1002 8/30/73 1:1000 36% 
Anti-PGEg 1010 10/14/73 1:4000 36% 
Anti-PGIg D-5 10/19/78 1:1000 62% 
Normal rabbit serum (MS) Pooled 6 10/25/76 1:400 2.6% 
Anti-rabbit gamma globulin Pooled 3 8/11/77 1:20 — 
Table 28. Phosphate buffered saline solution (PBS), O.OIM 
25 liters pH 7.0 
1. Dissolve in approximately 800 ml of distilled water (may require 
heating): 
a) 204.3 gm NaCl 
b) 9.85 gm NaHoPO^»H2O 
c) 26.7 gm NagHPO^ (anhydrous) or 49.5 gm of 7-hydrate 
d) 2.38 gm Merthlolate (EthylmercurithiosaHcylic Acid Sodium Salt) 
2. Dilute to 25 liters in large plastic carboy with distilled water. 
3. If pH la not within 9-7.1 range, adjust with 20% NaOH or 20% HCl. 
4. Store at 4°. 
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Table 29. Gelatin in phosphate buffer saline solution (PBS-gel), 0.1% 
1. Weigh 5 gms of Knox gelatin. 
2. Place approximately 600 ml of PBS in a 2-liter beaker. Add the gela­
tin, stir and heat. When the solution is clear, place in a large 
plastic container. Dilute to 5 liters with PBS. Mix well. Store 
at 4°. 
Table 30. PBS-EDTA, 0.05M 
1. Weigh 18.612 gms disodium EDTA (Ethylenediamine Tetraacetic Acid, 
FW 372.24, ('io^l4^2^^2^8 ^^2^^ ^ beaker. 
2. Add approximately 800 ml PBS. Warm and stir until dissolved. 
3. Bring pH to 7.0 with 5N NaOH. 
4. Transfer to 1-liter volumetric flask. When at room temperature, di­
lute to mark with PBS. Store at 4°. 
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Table 31. Representative protocol for PG-RIA 
P-l pi std. or Hi yl 
Tube No. PBS gel sample antiserum %-PG 
1 — — — 100 
2 — — — 100 
3 — — — 100 
4 500 — NRS:ARGG (1:1) 400 100 
5 500 — NRSiARGG (1:1) 400 100 
6 500 — NRS:ARGG (1:1) 400 100 
7 500 — Antiserum: ARGG (1:1) 400 100 
8 500 — Anti serum: ARGG (1:1) 400 100 
9 500 — Antiserum:ARGG (1:1) 400 100 
10 — 500 Antiserum:ARGG (1:1) 400 100 
11 250 250 Antiserum: ARGG (1:1) 400 100 
12 375 125 Antiserum:ARGG (1:1) 400 100 
13 437.5 62. 5 Antiserum: ARGG (1:1) 400 100 
14 468.8 31. 2 Antiserum; ARGG (1:1) 400 100 
15 484.4 15. 6 Antiserum; ARGG (1:1) 400 100 
16 492.2 7. 8 Anti serum ; ARGG (1:1) 400 100 
17 496.1 3. 9 Antiserum:ARGG (1:1) 400 100 
18 498.0 2. 0 Antiserum;ARGG (1:1) 400 100 
19 499.0 1. 0 Anti serum;ARGG (1:1) 400 100 
20 300 200 Antiserum:ARGG (1:1) 400 100 
21 300 200 Antiserum:ARGG (1:1) 400 100 
22 300 200 Antiserum:ARGG (1:1) 400 100 
23 300 200 Antiserum:ARGG (1:1) 400 100 
24 100 400 Antiserum: ARGG (1:1) 400 100 
25 100 400 Antiserum:ARGG (1:1) 400 100 
26 500 — Antiserum:ARGG (1:1) 400 100 
27 500 — Antiserum:ARGG (1:1) 400 100 
28 500 — Antiserum:ARGG (1:1) 400 100 
29 — 500 Antiserum;ARGG (1:1) 400 100 
30 250 250 Antiserum;ARGG (1:1) 400 100 
31 375 125 Ant1s erum:ARGG (1:1) 400 100 
32 437.5 62. 5 Antiserum:ARGG (1:1) 400 100 
33 468.8 31. 2 Antiserum:ARGG (1:1) 400 100 
34 484.4 15. 6 Ant1serum:ARGG (1:1) 400 100 
35 492.2 7. 8 Antiserum:ARGG (1:1) 400 100 
36 
37 
38 
ble 
tte 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
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Continued 
W'l til atd. or |il H-l 
PBS gel sample antiserum %-PG 
496.1 3.9 Antiserum:ARGG (1:1) 400 100 
498.0 2.0 Antiserum:ARGG (1:1) 400 100 
499.0 1.0 Anti serum : ARGG (1:1) 400 
Balanced incomplete block design. Experiment 11 
Treatments assigned 
0-T 1-T 5-T 10-T 
0-T 10-T 20-T EFAD 
1-T 5-T 20-T EFAD 
0-T 1-T 5-T 20-T 
0-T 1-T 10-T EFAD 
5-T 10-T 20-T EFAD 
0-T 1-T 5-T EFAD 
0-T 5-T 10-T 20-T 
1-T 10-T 20-T EFAD 
0-T 1-T 10-T 20-T 
0-T 5-T 20-T EFAD 
1-T 5-T 10-T EFAD 
0-T 1-T 20-T EFAD 
0-T 5-T 10-T EFAD 
1-T 5-T 10-T 20-T 
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Table 33. Influence of genetic variability on dependent variables. 
Experiment II 
Variable® PR > F 
Initial weight .01 
Weight gain 
(days 46-61) .05 
FER 
(days 1-43) .01 
Serum FA 
(46th day) 
16:0 .05 
16:1 .05 
18:0 .05 
18:1 .05 
18:2u)6 ' .01 
20;3u)9 .01 
(9l8t day) 
16:0 .05 
18:0 .01 
Lung FA 
16:0 .01 
18:1 .01 
18;2u)6 .01 
20:3(1)9 .05 
®Only those variables e^ibiting a statistically significant 
genetic effect are included. 
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Table 34. Influence of genetic variability on dependent variables. 
Experiment III 
Variable* PR > F 
Initial weight .01 
Weight at end of depletion 
(45 days) .01 
Weight on 76th day .01 
Weight on 82nd day .05 
Serum FA 
(91st day) 
C20:3(1)9 .05 
Lung FA 
C16:0 .05 
C18:0 .05 
C18;l .05 
C18;2tu6 .05 
C20;4u)6 .05 
Serum FGs 
FGEg .05 
Lung FGs 
FGE, .05 
FGFg .01 
FGI .05 
*0nly those variables exhibiting a statistically significant 
genetic effect are included. 
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